Quiver News
The latest insights and financial news from Quiver Quantitative
$10,000 of NEXTERA ENERGY RESOURCES DEVELOPMENT lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"issues related to solar energy project reviews"
You can find more data on corporate lobbying on Quiver Quantitative.
NEE Congressional Stock Trading
Members of Congress have traded $NEE stock 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $NEE stock by members of Congress over the last 6 months:
- REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/18, 11/13.
- REPRESENTATIVE RICHARD MCCORMICK purchased up to $15,000 on 11/05.
- REPRESENTATIVE THOMAS R. SUOZZI sold up to $15,000 on 10/14.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
NEE Insider Trading Activity
NEE insiders have traded $NEE stock on the open market 15 times in the past 6 months. Of those trades, 0 have been purchases and 15 have been sales.
Here’s a breakdown of recent trading of $NEE stock by insiders over the last 6 months:
- ARMANDO JR PIMENTEL sold 145,140 shares for an estimated $12,178,697
- JOHN W KETCHUM (Chairman, President & CEO) has made 0 purchases and 2 sales selling 99,603 shares for an estimated $8,898,532.
- RONALD R REAGAN (EVP, Eng., Const. & ISC) has made 0 purchases and 5 sales selling 46,654 shares for an estimated $4,063,996.
- CHARLES E SIEVING (EVP, Chief Legal) has made 0 purchases and 2 sales selling 41,336 shares for an estimated $3,606,880.
- JAMES MICHAEL MAY (Treasurer and Asst. Secretary) has made 0 purchases and 2 sales selling 7,161 shares for an estimated $646,423.
- NICOLE J DAGGS (EVP, Human Res & Corp Svcs) has made 0 purchases and 2 sales selling 4,934 shares for an estimated $458,862.
- MARK LEMASNEY (EVP Power Generation Division) sold 3,845 shares for an estimated $347,088
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
NEE Hedge Fund Activity
We have seen 1,374 institutional investors add shares of NEE stock to their portfolio, and 1,127 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 40,158,227 shares (-75.4%) from their portfolio in Q4 2025, for an estimated $3,223,902,463
- WELLINGTON MANAGEMENT GROUP LLP removed 7,240,301 shares (-61.7%) from their portfolio in Q4 2025, for an estimated $581,251,364
- CORIENT PRIVATE WEALTH LLC added 5,840,281 shares (+280.0%) to their portfolio in Q4 2025, for an estimated $468,857,758
- BLACKROCK, INC. added 5,474,250 shares (+3.2%) to their portfolio in Q4 2025, for an estimated $439,472,790
- JPMORGAN CHASE & CO added 5,027,929 shares (+5.2%) to their portfolio in Q4 2025, for an estimated $403,642,140
- STATE STREET CORP added 4,243,603 shares (+3.7%) to their portfolio in Q4 2025, for an estimated $340,676,448
- FMR LLC added 3,880,982 shares (+13.8%) to their portfolio in Q4 2025, for an estimated $311,565,234
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
NEE Analyst Ratings
Wall Street analysts have issued reports on $NEE in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 12/10/2025
- Citigroup issued a "Buy" rating on 10/29/2025
- Wells Fargo issued a "Overweight" rating on 10/28/2025
To track analyst ratings and price targets for NEE, check out Quiver Quantitative's $NEE forecast page.
NEE Price Targets
Multiple analysts have issued price targets for $NEE recently. We have seen 11 analysts offer price targets for $NEE in the last 6 months, with a median target of $92.0.
Here are some recent targets:
- William Appicelli from UBS set a target price of $104.0 on 03/05/2026
- Anthony Crowdell from Mizuho set a target price of $90.0 on 01/28/2026
- Marie Ferguson from Argus Research set a target price of $92.0 on 01/28/2026
- James Thalacker from BMO Capital set a target price of $93.0 on 01/27/2026
- Shahriar Pourreza from Wells Fargo set a target price of $98.0 on 01/20/2026
- Nicholas Campanella from Barclays set a target price of $85.0 on 01/15/2026
- Julien Dumoulin-Smith from Jefferies set a target price of $88.0 on 12/31/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$30,000 of REGIONS FINANCIAL CORPORATION lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues and legislation related to banking reform legislation, chartering and payment systems, London Interbank Offered Rate (LIBOR), and climate-risk policies; Monitoring Reconciliation and Infrastructure legislation Issues and legislation related to IRS tax reporting"
You can find more data on corporate lobbying on Quiver Quantitative.
RF Congressional Stock Trading
Members of Congress have traded $RF stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $RF stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
RF Insider Trading Activity
RF insiders have traded $RF stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $RF stock by insiders over the last 6 months:
- WILLIAM D. RITTER (SEVP) sold 36,000 shares for an estimated $1,036,062
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
RF Hedge Fund Activity
We have seen 474 institutional investors add shares of RF stock to their portfolio, and 397 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 24,689,248 shares (-76.2%) from their portfolio in Q4 2025, for an estimated $669,078,620
- VICTORY CAPITAL MANAGEMENT INC added 9,312,449 shares (+68.9%) to their portfolio in Q4 2025, for an estimated $252,367,367
- WELLINGTON MANAGEMENT GROUP LLP removed 6,545,641 shares (-15.6%) from their portfolio in Q4 2025, for an estimated $177,386,871
- FIRST TRUST ADVISORS LP added 4,125,776 shares (+118.6%) to their portfolio in Q4 2025, for an estimated $111,808,529
- BLACKROCK, INC. removed 3,181,795 shares (-3.7%) from their portfolio in Q4 2025, for an estimated $86,226,644
- BANK OF AMERICA CORP /DE/ removed 2,659,935 shares (-43.1%) from their portfolio in Q4 2025, for an estimated $72,084,238
- AMUNDI added 2,264,372 shares (+89.8%) to their portfolio in Q4 2025, for an estimated $61,364,481
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
RF Analyst Ratings
Wall Street analysts have issued reports on $RF in the last several months. We have seen 0 firms issue buy ratings on the stock, and 2 firms issue sell ratings.
Here are some recent analyst ratings:
- Evercore ISI Group issued a "Underperform" rating on 01/06/2026
- Barclays issued a "Underweight" rating on 01/05/2026
To track analyst ratings and price targets for RF, check out Quiver Quantitative's $RF forecast page.
RF Price Targets
Multiple analysts have issued price targets for $RF recently. We have seen 11 analysts offer price targets for $RF in the last 6 months, with a median target of $30.0.
Here are some recent targets:
- Betsy Graseck from Morgan Stanley set a target price of $34.0 on 03/31/2026
- Scott Siefers from Piper Sandler set a target price of $28.0 on 03/30/2026
- Brian Foran from Truist Securities set a target price of $28.0 on 03/23/2026
- Dave Rochester from Cantor Fitzgerald set a target price of $32.0 on 03/03/2026
- Vivek Juneja from JP Morgan set a target price of $31.5 on 02/09/2026
- Christopher McGratty from Keefe, Bruyette & Woods set a target price of $31.0 on 01/20/2026
- Mike Mayo from Wells Fargo set a target price of $28.0 on 01/20/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$40,000 of FIFTH THIRD BANCORP lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"General banking issues and prudential banking regulation"
You can find more data on corporate lobbying on Quiver Quantitative.
FITB Congressional Stock Trading
Members of Congress have traded $FITB stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $FITB stock by members of Congress over the last 6 months:
- REPRESENTATIVE DAVID TAYLOR has traded it 2 times. They made 1 purchase worth up to $15,000 on 03/11 and 1 sale worth up to $15,000 on 02/26.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
FITB Insider Trading Activity
FITB insiders have traded $FITB stock on the open market 16 times in the past 6 months. Of those trades, 2 have been purchases and 14 have been sales.
Here’s a breakdown of recent trading of $FITB stock by insiders over the last 6 months:
- MITCHELL STUART FEIGER has made 0 purchases and 7 sales selling 97,515 shares for an estimated $5,203,266.
- JUDE SCHRAMM (EVP & CIO) has made 0 purchases and 7 sales selling 17,146 shares for an estimated $866,639.
- EVAN BAYH has made 2 purchases buying 3,000 shares for an estimated $123,650 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
FITB Hedge Fund Activity
We have seen 531 institutional investors add shares of FITB stock to their portfolio, and 416 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 14,742,962 shares (-75.4%) from their portfolio in Q4 2025, for an estimated $690,118,051
- PRICE T ROWE ASSOCIATES INC /MD/ added 10,444,799 shares (+41.6%) to their portfolio in Q4 2025, for an estimated $488,921,041
- APG ASSET MANAGEMENT N.V. added 6,037,584 shares (+1066.1%) to their portfolio in Q4 2025, for an estimated $282,619,307
- NORGES BANK added 5,179,709 shares (+59.6%) to their portfolio in Q4 2025, for an estimated $242,462,178
- CLEARBRIDGE INVESTMENTS, LLC added 2,644,332 shares (+719.2%) to their portfolio in Q4 2025, for an estimated $123,781,180
- INVESCO LTD. added 2,574,712 shares (+12.1%) to their portfolio in Q4 2025, for an estimated $120,522,268
- MARSHALL WACE, LLP removed 2,216,160 shares (-89.8%) from their portfolio in Q4 2025, for an estimated $103,738,449
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
FITB Analyst Ratings
Wall Street analysts have issued reports on $FITB in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 01/05/2026
- Piper Sandler issued a "Overweight" rating on 12/10/2025
- TD Cowen issued a "Buy" rating on 10/20/2025
- DA Davidson issued a "Buy" rating on 10/08/2025
- Morgan Stanley issued a "Overweight" rating on 10/07/2025
To track analyst ratings and price targets for FITB, check out Quiver Quantitative's $FITB forecast page.
FITB Price Targets
Multiple analysts have issued price targets for $FITB recently. We have seen 14 analysts offer price targets for $FITB in the last 6 months, with a median target of $56.0.
Here are some recent targets:
- Scott Siefers from Piper Sandler set a target price of $54.0 on 03/30/2026
- Vivek Juneja from JP Morgan set a target price of $50.5 on 03/16/2026
- Brian Foran from Truist Securities set a target price of $53.0 on 03/13/2026
- Manan Gosalia from Morgan Stanley set a target price of $67.0 on 03/02/2026
- John Pancari from Evercore ISI Group set a target price of $57.0 on 02/05/2026
- Steven Alexopoulos from TD Cowen set a target price of $60.0 on 02/03/2026
- Peter Winter from DA Davidson set a target price of $58.0 on 01/26/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$20,000 of S&P GLOBAL F/K/A IHS MARITIME & TRADE lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Container Security Issues, Transportation Cargo Security Maritime Transport Data Collections and Use"
You can find more data on corporate lobbying on Quiver Quantitative.
SPGI Congressional Stock Trading
Members of Congress have traded $SPGI stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $SPGI stock by members of Congress over the last 6 months:
- REPRESENTATIVE RICK W. ALLEN purchased up to $50,000 on 01/14.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
SPGI Insider Trading Activity
SPGI insiders have traded $SPGI stock on the open market 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $SPGI stock by insiders over the last 6 months:
- HUBERT JOLY has made 2 purchases buying 2,500 shares for an estimated $997,459 and 0 sales.
- WILLIAM W EAGER (President, S&P Global Mobility) purchased 12 shares for an estimated $5,963
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
SPGI Hedge Fund Activity
We have seen 926 institutional investors add shares of SPGI stock to their portfolio, and 918 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 8,312,857 shares (-74.9%) from their portfolio in Q4 2025, for an estimated $4,344,215,939
- LOMBARD ODIER ASSET MANAGEMENT (EUROPE) LTD removed 2,438,336 shares (-98.1%) from their portfolio in Q4 2025, for an estimated $1,274,250,010
- DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN removed 1,710,698 shares (-66.1%) from their portfolio in Q4 2025, for an estimated $893,993,667
- ROCKEFELLER CAPITAL MANAGEMENT L.P. added 1,590,398 shares (+2487.8%) to their portfolio in Q4 2025, for an estimated $831,126,090
- CARDANO RISK MANAGEMENT B.V. added 1,576,544 shares (+858.3%) to their portfolio in Q4 2025, for an estimated $823,886,128
- WELLINGTON MANAGEMENT GROUP LLP removed 1,449,765 shares (-23.3%) from their portfolio in Q4 2025, for an estimated $757,632,691
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 981,451 shares (+1598.9%) to their portfolio in Q4 2025, for an estimated $512,896,478
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
SPGI Analyst Ratings
Wall Street analysts have issued reports on $SPGI in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Stifel issued a "Buy" rating on 10/31/2025
- JP Morgan issued a "Overweight" rating on 10/31/2025
- Mizuho issued a "Outperform" rating on 10/16/2025
- BMO Capital issued a "Outperform" rating on 10/16/2025
- Evercore ISI Group issued a "Outperform" rating on 10/14/2025
To track analyst ratings and price targets for SPGI, check out Quiver Quantitative's $SPGI forecast page.
SPGI Price Targets
Multiple analysts have issued price targets for $SPGI recently. We have seen 10 analysts offer price targets for $SPGI in the last 6 months, with a median target of $550.5.
Here are some recent targets:
- Jeffrey Silber from BMO Capital set a target price of $495.0 on 03/17/2026
- Alex Kramm from UBS set a target price of $550.0 on 02/17/2026
- Sean Kennedy from Mizuho set a target price of $551.0 on 02/12/2026
- Shlomo Rosenbaum from Stifel set a target price of $489.0 on 02/11/2026
- Jason Haas from Wells Fargo set a target price of $530.0 on 02/11/2026
- David Motemeden from Evercore ISI Group set a target price of $625.0 on 02/11/2026
- George Tong from Goldman Sachs set a target price of $498.0 on 02/11/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$30,000 of HUDBAY MINERALS INC. lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Introduced companys domestic source of made in America copper projects to several Congressional Members."
You can find more data on corporate lobbying on Quiver Quantitative.
HBM Hedge Fund Activity
We have seen 130 institutional investors add shares of HBM stock to their portfolio, and 150 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FIL LTD added 22,169,339 shares (+202.0%) to their portfolio in Q4 2025, for an estimated $440,061,379
- L1 CAPITAL PTY LTD removed 8,379,964 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $166,342,285
- DONALD SMITH & CO., INC. removed 5,725,208 shares (-99.4%) from their portfolio in Q4 2025, for an estimated $113,645,378
- MACKENZIE FINANCIAL CORP added 5,468,109 shares (+116.1%) to their portfolio in Q4 2025, for an estimated $108,541,963
- ACADIAN ASSET MANAGEMENT LLC added 4,693,200 shares (+92.2%) to their portfolio in Q4 2025, for an estimated $93,160,020
- FMR LLC added 4,125,426 shares (+139.2%) to their portfolio in Q4 2025, for an estimated $81,889,706
- GMT CAPITAL CORP removed 3,462,400 shares (-12.3%) from their portfolio in Q4 2025, for an estimated $68,728,640
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
HBM Analyst Ratings
Wall Street analysts have issued reports on $HBM in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- RBC Capital issued a "Outperform" rating on 11/17/2025
- Scotiabank issued a "Sector Outperform" rating on 11/13/2025
To track analyst ratings and price targets for HBM, check out Quiver Quantitative's $HBM forecast page.
HBM Price Targets
Multiple analysts have issued price targets for $HBM recently. We have seen 6 analysts offer price targets for $HBM in the last 6 months, with a median target of $29.25.
Here are some recent targets:
- Orest Wowkodaw from Scotiabank set a target price of $35.5 on 02/23/2026
- Alexander Hacking from Citigroup set a target price of $32.5 on 02/11/2026
- George Eadie from UBS set a target price of $38.5 on 02/03/2026
- Sam Crittenden from RBC Capital set a target price of $26.0 on 11/17/2025
- Lawson Winder from B of A Securities set a target price of $19.5 on 10/16/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$31,700 of LOCKHEED MARTIN AERONAUTIC SECTOR lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Armed Services Committee: tactical aircraft issues, space based radar;GP;C-130J;foreign military sales; support helicopter funding; support space hardening; JASSM funding; support JADC2; monitor for defense spectrum issues Defense Appropriation: tactical aircraft issues, space based radar;GP;C-130J;foreign military sales; support helicopter funding; support space hardening; JASSM funding;support funding for helicopters and equipment for wildfire firefighting ratification of law of the sea support defense financing provisions monitor for provisions related to corporate SALT taxation"
You can find more data on corporate lobbying on Quiver Quantitative.
LMT Congressional Stock Trading
Members of Congress have traded $LMT stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $LMT stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $15,000 on 11/18 and 1 sale worth up to $15,000 on 12/19.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
LMT Insider Trading Activity
LMT insiders have traded $LMT stock on the open market 15 times in the past 6 months. Of those trades, 0 have been purchases and 15 have been sales.
Here’s a breakdown of recent trading of $LMT stock by insiders over the last 6 months:
- JOHN FRANK A ST (Chief Operating Officer) has made 0 purchases and 3 sales selling 7,792 shares for an estimated $3,826,166.
- STEPHANIE C. HILL (Pres. Rotary & Mission Systems) has made 0 purchases and 2 sales selling 2,410 shares for an estimated $6,660.
- GREGORY M ULMER (President Aeronautics) has made 0 purchases and 2 sales selling 2,840 shares for an estimated $0.
- TIMOTHY S CAHILL (Pres. Missiles & Fire Control) has made 0 purchases and 8 sales selling 4,620 shares for an estimated $0.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
LMT Hedge Fund Activity
We have seen 1,129 institutional investors add shares of LMT stock to their portfolio, and 1,165 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 1,509,057 shares (-77.5%) from their portfolio in Q4 2025, for an estimated $729,885,599
- CAPITAL WORLD INVESTORS removed 1,035,763 shares (-36.3%) from their portfolio in Q4 2025, for an estimated $500,967,490
- BLACKROCK, INC. added 851,976 shares (+5.1%) to their portfolio in Q4 2025, for an estimated $412,075,231
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 828,827 shares (-96.0%) from their portfolio in Q4 2025, for an estimated $400,878,755
- D. E. SHAW & CO., INC. added 699,458 shares (+109.1%) to their portfolio in Q4 2025, for an estimated $338,306,850
- AQR CAPITAL MANAGEMENT LLC added 669,604 shares (+107.3%) to their portfolio in Q4 2025, for an estimated $323,867,366
- BALYASNY ASSET MANAGEMENT L.P. removed 659,551 shares (-98.2%) from their portfolio in Q4 2025, for an estimated $319,005,032
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
LMT Analyst Ratings
Wall Street analysts have issued reports on $LMT in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Truist Securities issued a "Buy" rating on 01/09/2026
- Morgan Stanley issued a "Overweight" rating on 10/15/2025
- Susquehanna issued a "Positive" rating on 10/09/2025
- Baird issued a "Outperform" rating on 10/06/2025
To track analyst ratings and price targets for LMT, check out Quiver Quantitative's $LMT forecast page.
LMT Price Targets
Multiple analysts have issued price targets for $LMT recently. We have seen 13 analysts offer price targets for $LMT in the last 6 months, with a median target of $630.0.
Here are some recent targets:
- John Godyn from Citigroup set a target price of $675.0 on 04/02/2026
- David Strauss from Wells Fargo set a target price of $650.0 on 04/01/2026
- Charles Minervino from Susquehanna set a target price of $740.0 on 03/18/2026
- Noah Poponak from Goldman Sachs set a target price of $517.0 on 02/02/2026
- Gavin Parsons from UBS set a target price of $663.0 on 02/02/2026
- Sheila Kahyaoglu from Jefferies set a target price of $630.0 on 02/02/2026
- Ken Herbert from RBC Capital set a target price of $650.0 on 01/30/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$52,500 of ZIONS BANCORP lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"monitor for legislation affecting small business loans support Congressional efforts to require large credit unions to become taxable support legislation to require credit unions to be transparent monitor legislation regarding ESG oppose the use of the USPS for banking work to mitigate proposed SEC rule on ESG monitor assessment date for FDIC insurance recapitalization monitor for legislation regarding long term debt regulations"
You can find more data on corporate lobbying on Quiver Quantitative.
TBBK Insider Trading Activity
TBBK insiders have traded $TBBK stock on the open market 18 times in the past 6 months. Of those trades, 17 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $TBBK stock by insiders over the last 6 months:
- DOMINIC C CANUSO (EVP & Chief Financial Officer) has made 7 purchases buying 8,500 shares for an estimated $513,402 and 0 sales.
- MARK E TRYNISKI purchased 5,000 shares for an estimated $301,158
- MATTHEW COHN has made 9 purchases buying 4,725 shares for an estimated $291,442 and 0 sales.
- RYAN HARRIS (EVP Head of Fintech Solutions) sold 4,500 shares for an estimated $239,328
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
TBBK Hedge Fund Activity
We have seen 97 institutional investors add shares of TBBK stock to their portfolio, and 186 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 497,146 shares (-12.0%) from their portfolio in Q4 2025, for an estimated $33,567,297
- WELLINGTON MANAGEMENT GROUP LLP removed 384,535 shares (-27.3%) from their portfolio in Q4 2025, for an estimated $25,963,803
- BALYASNY ASSET MANAGEMENT L.P. removed 361,370 shares (-96.9%) from their portfolio in Q4 2025, for an estimated $24,399,702
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 332,979 shares (-75.0%) from their portfolio in Q4 2025, for an estimated $22,482,742
- BLACKROCK, INC. removed 265,837 shares (-4.1%) from their portfolio in Q4 2025, for an estimated $17,949,314
- JANUS HENDERSON GROUP PLC removed 262,192 shares (-22.3%) from their portfolio in Q4 2025, for an estimated $17,703,203
- BREVAN HOWARD CAPITAL MANAGEMENT LP added 255,948 shares (+7287.8%) to their portfolio in Q4 2025, for an estimated $17,281,608
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$60,000 of HEALTHPEAK PROPERTIES INC. FKA PHYSICIANS REALTY TRUST lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"monitor legislation affecting real estate investment trusts oppose legislation prohibiting REITs ownership of healthcare property; monitor BioSecure legislation oppose adoption of Corporate SALT provisions monitor legislation affecting site neutral cuts in Medicare"
You can find more data on corporate lobbying on Quiver Quantitative.
DOC Congressional Stock Trading
Members of Congress have traded $DOC stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $DOC stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $15,000 on 01/09 and 1 sale worth up to $15,000 on 02/10.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
DOC Hedge Fund Activity
We have seen 327 institutional investors add shares of DOC stock to their portfolio, and 377 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 32,060,585 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $515,534,206
- CENTERSQUARE INVESTMENT MANAGEMENT LLC removed 8,901,289 shares (-63.0%) from their portfolio in Q4 2025, for an estimated $143,132,727
- FMR LLC added 6,380,786 shares (+153.4%) to their portfolio in Q4 2025, for an estimated $102,603,038
- FULLER & THALER ASSET MANAGEMENT, INC. added 4,776,056 shares (+19.2%) to their portfolio in Q4 2025, for an estimated $76,798,980
- BANK OF NEW YORK MELLON CORP added 2,887,084 shares (+42.7%) to their portfolio in Q4 2025, for an estimated $46,424,310
- MILLENNIUM MANAGEMENT LLC added 2,464,612 shares (+235.3%) to their portfolio in Q4 2025, for an estimated $39,630,960
- JPMORGAN CHASE & CO added 2,438,278 shares (+8.6%) to their portfolio in Q4 2025, for an estimated $39,207,510
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
DOC Price Targets
Multiple analysts have issued price targets for $DOC recently. We have seen 6 analysts offer price targets for $DOC in the last 6 months, with a median target of $17.75.
Here are some recent targets:
- Nick Joseph from Citigroup set a target price of $17.5 on 04/01/2026
- James Kammert from Evercore ISI Group set a target price of $19.0 on 02/04/2026
- John Kilichowski from Wells Fargo set a target price of $18.0 on 02/02/2026
- Julien Blouin from Goldman Sachs set a target price of $17.0 on 01/09/2026
- Jonathan Petersen from Jefferies set a target price of $17.0 on 12/16/2025
- Amanda Sweitzer from Baird set a target price of $20.0 on 11/12/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$10,000 of SCIENCE APPLICATIONS INTERNATIONAL CORPORATION lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"DOD RDT&E issues."
You can find more data on corporate lobbying on Quiver Quantitative.
SAIC Congressional Stock Trading
Members of Congress have traded $SAIC stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $SAIC stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
SAIC Insider Trading Activity
SAIC insiders have traded $SAIC stock on the open market 5 times in the past 6 months. Of those trades, 5 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $SAIC stock by insiders over the last 6 months:
- PRABU NATARAJAN (EVP, Chief Financial Officer) purchased 2,000 shares for an estimated $200,976
- JAMES REAGAN (Interim CEO) purchased 1,000 shares for an estimated $100,165
- SRINIVAS ATTILI (EVP, Civilian) has made 2 purchases buying 200 shares for an estimated $19,861 and 0 sales.
- HILARY HAGEMAN (EVP General Counsel, Secretary) purchased 100 shares for an estimated $10,021
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
SAIC Hedge Fund Activity
We have seen 164 institutional investors add shares of SAIC stock to their portfolio, and 227 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 860,151 shares (-28.7%) from their portfolio in Q4 2025, for an estimated $86,582,799
- WELLINGTON MANAGEMENT GROUP LLP removed 765,208 shares (-90.6%) from their portfolio in Q4 2025, for an estimated $77,025,837
- FULLER & THALER ASSET MANAGEMENT, INC. added 441,296 shares (+20.2%) to their portfolio in Q4 2025, for an estimated $44,420,855
- WOODLINE PARTNERS LP added 437,452 shares (+inf%) to their portfolio in Q4 2025, for an estimated $44,033,918
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 416,570 shares (-79.9%) from their portfolio in Q4 2025, for an estimated $41,931,936
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 399,371 shares (-64.1%) from their portfolio in Q4 2025, for an estimated $40,200,684
- FIRST TRUST ADVISORS LP added 393,344 shares (+25.9%) to their portfolio in Q4 2025, for an estimated $39,594,007
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
SAIC Analyst Ratings
Wall Street analysts have issued reports on $SAIC in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Buy" rating on 01/13/2026
To track analyst ratings and price targets for SAIC, check out Quiver Quantitative's $SAIC forecast page.
SAIC Price Targets
Multiple analysts have issued price targets for $SAIC recently. We have seen 6 analysts offer price targets for $SAIC in the last 6 months, with a median target of $116.5.
Here are some recent targets:
- Tobey Sommer from Truist Securities set a target price of $95.0 on 03/17/2026
- Jonathan Siegmann from Stifel set a target price of $120.0 on 03/17/2026
- Gavin Parsons from Goldman Sachs set a target price of $82.0 on 02/12/2026
- John Godyn from Citigroup set a target price of $133.0 on 01/13/2026
- Gavin Parsons from UBS set a target price of $113.0 on 12/08/2025
- Seth Seifman from JP Morgan set a target price of $125.0 on 12/05/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$30,000 of MICROCHIP TECHNOLOGY INC. (FKA MICROSEMI) lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Microchip manufacturing issues."
You can find more data on corporate lobbying on Quiver Quantitative.
MCHP Insider Trading Activity
MCHP insiders have traded $MCHP stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $MCHP stock by insiders over the last 6 months:
- STEVE SANGHI (President, CEO and Chair of Bd) has made 0 purchases and 3 sales selling 212,192 shares for an estimated $17,248,888.
- MATHEW B BUNKER (SENIOR VP, OPERATIONS) sold 10,000 shares for an estimated $783,700
- JAMES ERIC BJORNHOLT (SENIOR VP AND CFO) has made 0 purchases and 3 sales selling 9,822 shares for an estimated $646,261.
- JOSEPH R II KRAWCZYK (SR. VP, WW CLIENT ENGAGEMENT) sold 4,400 shares for an estimated $345,743
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
MCHP Hedge Fund Activity
We have seen 458 institutional investors add shares of MCHP stock to their portfolio, and 578 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 8,688,217 shares (-74.9%) from their portfolio in Q4 2025, for an estimated $553,613,187
- BARCLAYS PLC added 5,590,210 shares (+66.5%) to their portfolio in Q4 2025, for an estimated $356,208,181
- NORGES BANK added 3,703,281 shares (+55.1%) to their portfolio in Q4 2025, for an estimated $235,973,065
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 2,977,562 shares (-31.4%) from their portfolio in Q4 2025, for an estimated $189,730,250
- JANE STREET GROUP, LLC removed 2,008,270 shares (-80.9%) from their portfolio in Q4 2025, for an estimated $127,966,964
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 1,719,323 shares (+426.7%) to their portfolio in Q4 2025, for an estimated $109,555,261
- AMUNDI added 1,620,645 shares (+50.7%) to their portfolio in Q4 2025, for an estimated $103,267,499
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
MCHP Analyst Ratings
Wall Street analysts have issued reports on $MCHP in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Cantor Fitzgerald issued a "Overweight" rating on 02/02/2026
- Piper Sandler issued a "Overweight" rating on 01/15/2026
- Mizuho issued a "Outperform" rating on 01/09/2026
- Needham issued a "Buy" rating on 01/06/2026
- Rosenblatt issued a "Buy" rating on 01/06/2026
- JP Morgan issued a "Overweight" rating on 01/06/2026
- Stifel issued a "Buy" rating on 11/07/2025
To track analyst ratings and price targets for MCHP, check out Quiver Quantitative's $MCHP forecast page.
MCHP Price Targets
Multiple analysts have issued price targets for $MCHP recently. We have seen 17 analysts offer price targets for $MCHP in the last 6 months, with a median target of $90.0.
Here are some recent targets:
- Tom O'Malley from Barclays set a target price of $80.0 on 02/13/2026
- William Stein from Truist Securities set a target price of $69.0 on 02/11/2026
- Matthew Prisco from Cantor Fitzgerald set a target price of $100.0 on 02/06/2026
- Christopher Danely from Citigroup set a target price of $91.0 on 02/06/2026
- Joe Quatrochi from Wells Fargo set a target price of $70.0 on 02/06/2026
- Harlan Sur from JP Morgan set a target price of $95.0 on 02/06/2026
- N. Quinn Bolton from Needham set a target price of $84.0 on 02/06/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$30,000 of ENERSYS ENERGY PRODUCTS INC. lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"DOD Battery issues."
You can find more data on corporate lobbying on Quiver Quantitative.
ENS Insider Trading Activity
ENS insiders have traded $ENS stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $ENS stock by insiders over the last 6 months:
- CHAD C UPLINGER (President Motive Power Global) has made 0 purchases and 2 sales selling 6,702 shares for an estimated $1,015,084.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ENS Hedge Fund Activity
We have seen 225 institutional investors add shares of ENS stock to their portfolio, and 184 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 632,398 shares (+14.1%) to their portfolio in Q4 2025, for an estimated $92,804,406
- DEPRINCE RACE & ZOLLO INC removed 489,082 shares (-46.9%) from their portfolio in Q4 2025, for an estimated $71,772,783
- LSV ASSET MANAGEMENT added 421,338 shares (+298.9%) to their portfolio in Q4 2025, for an estimated $61,831,351
- INVESCO LTD. removed 371,048 shares (-32.0%) from their portfolio in Q4 2025, for an estimated $54,451,294
- MILLENNIUM MANAGEMENT LLC removed 334,072 shares (-60.0%) from their portfolio in Q4 2025, for an estimated $49,025,066
- PRICE T ROWE ASSOCIATES INC /MD/ added 304,018 shares (+342.5%) to their portfolio in Q4 2025, for an estimated $44,614,641
- ACK ASSET MANAGEMENT LLC removed 280,000 shares (-47.9%) from their portfolio in Q4 2025, for an estimated $41,090,000
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ENS Analyst Ratings
Wall Street analysts have issued reports on $ENS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 12/15/2025
To track analyst ratings and price targets for ENS, check out Quiver Quantitative's $ENS forecast page.
ENS Price Targets
Multiple analysts have issued price targets for $ENS recently. We have seen 3 analysts offer price targets for $ENS in the last 6 months, with a median target of $186.0.
Here are some recent targets:
- Gregory Lewis from BTIG set a target price of $185.0 on 02/05/2026
- Chip Moore from Roth Capital set a target price of $208.0 on 02/03/2026
- Noah Kaye from Oppenheimer set a target price of $186.0 on 01/20/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$40,000 of CASTLE BIOSCIENCES INC. lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues relating to Medicare coverage for laboratory diagnostic services."
You can find more data on corporate lobbying on Quiver Quantitative.
CSTL Insider Trading Activity
CSTL insiders have traded $CSTL stock on the open market 56 times in the past 6 months. Of those trades, 0 have been purchases and 56 have been sales.
Here’s a breakdown of recent trading of $CSTL stock by insiders over the last 6 months:
- DEREK J MAETZOLD (Pres. & Chief Exec. Officer) has made 0 purchases and 41 sales selling 172,231 shares for an estimated $5,287,058.
- KRISTEN M OELSCHLAGER (Chief Operating Officer) has made 0 purchases and 3 sales selling 46,498 shares for an estimated $1,567,262.
- TOBIN W JUVENAL (Chief Commercial Officer) has made 0 purchases and 5 sales selling 39,456 shares for an estimated $1,213,070.
- FRANK STOKES (Chief Financial Officer) has made 0 purchases and 5 sales selling 22,885 shares for an estimated $717,367.
- G BRADLEY COLE has made 0 purchases and 2 sales selling 7,403 shares for an estimated $210,727.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CSTL Hedge Fund Activity
We have seen 101 institutional investors add shares of CSTL stock to their portfolio, and 85 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- RTW INVESTMENTS, LP added 2,115,237 shares (+inf%) to their portfolio in Q4 2025, for an estimated $82,282,719
- SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC added 658,725 shares (+164.7%) to their portfolio in Q4 2025, for an estimated $25,624,402
- BRAIDWELL LP removed 645,552 shares (-78.5%) from their portfolio in Q4 2025, for an estimated $25,111,972
- NUVEEN, LLC removed 432,400 shares (-45.2%) from their portfolio in Q4 2025, for an estimated $16,820,360
- DIMENSIONAL FUND ADVISORS LP removed 330,290 shares (-22.4%) from their portfolio in Q4 2025, for an estimated $12,848,281
- PARKMAN HEALTHCARE PARTNERS LLC removed 325,010 shares (-68.3%) from their portfolio in Q4 2025, for an estimated $12,642,889
- EVENTIDE ASSET MANAGEMENT, LLC added 305,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $11,864,500
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CSTL Analyst Ratings
Wall Street analysts have issued reports on $CSTL in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Lake Street issued a "Buy" rating on 01/12/2026
- Canaccord Genuity issued a "Buy" rating on 12/22/2025
- BTIG issued a "Buy" rating on 11/05/2025
- Baird issued a "Outperform" rating on 11/04/2025
To track analyst ratings and price targets for CSTL, check out Quiver Quantitative's $CSTL forecast page.
CSTL Price Targets
Multiple analysts have issued price targets for $CSTL recently. We have seen 5 analysts offer price targets for $CSTL in the last 6 months, with a median target of $50.0.
Here are some recent targets:
- Catherine Ramsey from Baird set a target price of $44.0 on 02/27/2026
- Subbu Nambi from Guggenheim set a target price of $47.0 on 01/26/2026
- Thomas Flaten from Lake Street set a target price of $52.0 on 01/12/2026
- Kyle Mikson from Canaccord Genuity set a target price of $50.0 on 12/22/2025
- Mark Massaro from BTIG set a target price of $50.0 on 12/12/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$50,000 of PDV WIRELESS (NOW DBA ANTERIX) lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to spectrum policy and the deployment of broadband service in the 900 MHz band Issues related to energy grid modernization and the deployment of private communications networks by utilities"
You can find more data on corporate lobbying on Quiver Quantitative.
ATEX Insider Trading Activity
ATEX insiders have traded $ATEX stock on the open market 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $ATEX stock by insiders over the last 6 months:
- GENA L ASHE (Chief Legal Officer & Corp Sec) sold 6,564 shares for an estimated $138,303
- SCOTT A. LANG (President and CEO) has made 2 purchases buying 3,610 shares for an estimated $75,072 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ATEX Hedge Fund Activity
We have seen 58 institutional investors add shares of ATEX stock to their portfolio, and 61 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DG CAPITAL MANAGEMENT, LLC removed 723,299 shares (-97.1%) from their portfolio in Q4 2025, for an estimated $15,789,617
- JEFFERIES FINANCIAL GROUP INC. added 454,508 shares (+inf%) to their portfolio in Q4 2025, for an estimated $9,921,909
- MILLENNIUM MANAGEMENT LLC added 404,838 shares (+1153.1%) to their portfolio in Q4 2025, for an estimated $8,837,613
- FMR LLC removed 236,745 shares (-82.3%) from their portfolio in Q4 2025, for an estimated $5,168,143
- SCOGGIN MANAGEMENT LP removed 225,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $4,911,750
- POTOMAC CAPITAL MANAGEMENT, INC. added 161,400 shares (+inf%) to their portfolio in Q4 2025, for an estimated $3,523,361
- JANE STREET GROUP, LLC added 116,731 shares (+276.1%) to their portfolio in Q4 2025, for an estimated $2,548,237
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$30,000 of DAVITA INC. lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"None"
You can find more data on corporate lobbying on Quiver Quantitative.
DVA Insider Trading Activity
DVA insiders have traded $DVA stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $DVA stock by insiders over the last 6 months:
- HATHAWAY INC BERKSHIRE has made 0 purchases and 2 sales selling 2,059,994 shares for an estimated $254,287,129.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
DVA Hedge Fund Activity
We have seen 233 institutional investors add shares of DVA stock to their portfolio, and 305 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 1,205,195 shares (-90.1%) from their portfolio in Q4 2025, for an estimated $136,922,203
- BLACKROCK, INC. removed 649,620 shares (-18.2%) from their portfolio in Q4 2025, for an estimated $73,803,328
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 636,191 shares (+114.9%) to their portfolio in Q4 2025, for an estimated $72,277,659
- D. E. SHAW & CO., INC. added 429,555 shares (+566.9%) to their portfolio in Q4 2025, for an estimated $48,801,743
- BERKSHIRE HATHAWAY INC removed 401,514 shares (-1.2%) from their portfolio in Q4 2025, for an estimated $45,616,005
- STATE STREET CORP removed 396,341 shares (-21.6%) from their portfolio in Q4 2025, for an estimated $45,028,301
- MILLENNIUM MANAGEMENT LLC added 394,444 shares (+86.1%) to their portfolio in Q4 2025, for an estimated $44,812,782
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
DVA Price Targets
Multiple analysts have issued price targets for $DVA recently. We have seen 3 analysts offer price targets for $DVA in the last 6 months, with a median target of $158.0.
Here are some recent targets:
- Andrew Mok from UBS set a target price of $190.0 on 02/04/2026
- Andrew Mok from Barclays set a target price of $158.0 on 02/03/2026
- Ryan Langston from TD Cowen set a target price of $133.0 on 11/03/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$20,000 of CADENCE DESIGN SYSTEMS INC lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"None"
You can find more data on corporate lobbying on Quiver Quantitative.
CDNS Insider Trading Activity
CDNS insiders have traded $CDNS stock on the open market 38 times in the past 6 months. Of those trades, 0 have been purchases and 38 have been sales.
Here’s a breakdown of recent trading of $CDNS stock by insiders over the last 6 months:
- JOHN M WALL (Sr. VP & CFO) has made 0 purchases and 4 sales selling 27,805 shares for an estimated $8,857,772.
- ANIRUDH DEVGAN (President and CEO) has made 0 purchases and 7 sales selling 25,550 shares for an estimated $8,619,279.
- CHIN-CHI TENG (Sr. Vice President) has made 0 purchases and 3 sales selling 18,096 shares for an estimated $5,914,007.
- PAUL SCANNELL (Sr. Vice President) has made 0 purchases and 2 sales selling 5,490 shares for an estimated $1,863,494.
- PAUL CUNNINGHAM (Sr. Vice President) has made 0 purchases and 5 sales selling 5,000 shares for an estimated $1,561,470.
- ITA M BRENNAN has made 0 purchases and 15 sales selling 360 shares for an estimated $113,851.
- MOSHE GAVRIELOV has made 0 purchases and 2 sales selling 25 shares for an estimated $7,898.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CDNS Hedge Fund Activity
We have seen 679 institutional investors add shares of CDNS stock to their portfolio, and 635 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 11,429,245 shares (-75.5%) from their portfolio in Q4 2025, for an estimated $3,572,553,402
- J. STERN & CO. LLP added 2,924,470 shares (+10159.3%) to their portfolio in Q4 2025, for an estimated $914,130,832
- BLACKROCK, INC. removed 2,686,173 shares (-9.3%) from their portfolio in Q4 2025, for an estimated $839,643,956
- WELLINGTON MANAGEMENT GROUP LLP added 1,751,290 shares (+218.4%) to their portfolio in Q4 2025, for an estimated $547,418,228
- JENNISON ASSOCIATES LLC removed 1,016,098 shares (-11.6%) from their portfolio in Q4 2025, for an estimated $317,611,912
- FRANKLIN RESOURCES INC removed 860,775 shares (-21.8%) from their portfolio in Q4 2025, for an estimated $269,061,049
- BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. added 760,556 shares (+240.8%) to their portfolio in Q4 2025, for an estimated $237,734,594
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CDNS Analyst Ratings
Wall Street analysts have issued reports on $CDNS in the last several months. We have seen 6 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Morgan Stanley issued a "Overweight" rating on 02/18/2026
- Needham issued a "Buy" rating on 02/18/2026
- Citigroup issued a "Buy" rating on 11/24/2025
- Baird issued a "Outperform" rating on 10/28/2025
- JP Morgan issued a "Overweight" rating on 10/28/2025
- Oppenheimer issued a "Underperform" rating on 10/28/2025
- Wells Fargo issued a "Overweight" rating on 10/28/2025
To track analyst ratings and price targets for CDNS, check out Quiver Quantitative's $CDNS forecast page.
CDNS Price Targets
Multiple analysts have issued price targets for $CDNS recently. We have seen 9 analysts offer price targets for $CDNS in the last 6 months, with a median target of $375.0.
Here are some recent targets:
- Blair Abernethy from Rosenblatt set a target price of $360.0 on 02/26/2026
- Clarke Jeffries from Piper Sandler set a target price of $319.0 on 02/18/2026
- Lee Simpson from Morgan Stanley set a target price of $370.0 on 02/18/2026
- Charles Shi from Needham set a target price of $390.0 on 02/18/2026
- Joe Quatrochi from Wells Fargo set a target price of $375.0 on 02/18/2026
- Kelsey Chia from Citigroup set a target price of $385.0 on 11/24/2025
- Joe Vruwink from Baird set a target price of $418.0 on 10/28/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$740,000 of LUMEN TECHNOLOGIES INC. lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Policies enabling expansion of data center connectivity to facilitate artificial intelligence capabilities. Implementation and funding for the FCC Secure and Trusted Communications Networks Program. Policies to streamline federal and state permitting and rights of way for broadband and connectivity infrastructure. Reform of FCC policies on discontinuance of voice service. Federal cybersecurity policies; HR 2784, the Stopping the Theft and Destruction of Broadband Act; Federal procurement policies for telecommunications in the National Defense Authorization Act."
You can find more data on corporate lobbying on Quiver Quantitative.
LUMN Insider Trading Activity
LUMN insiders have traded $LUMN stock on the open market 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $LUMN stock by insiders over the last 6 months:
- KATHLEEN E JOHNSON (President & CEO) purchased 78,685 shares for an estimated $499,925
- DIANKHA LINEAR sold 45,000 shares for an estimated $355,050
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
LUMN Hedge Fund Activity
We have seen 292 institutional investors add shares of LUMN stock to their portfolio, and 197 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO added 16,731,426 shares (+305.3%) to their portfolio in Q4 2025, for an estimated $130,003,180
- FMR LLC added 16,323,057 shares (+162.1%) to their portfolio in Q4 2025, for an estimated $126,830,152
- BRIGADE CAPITAL MANAGEMENT, LP removed 9,750,000 shares (-84.1%) from their portfolio in Q4 2025, for an estimated $75,757,500
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 8,071,919 shares (-74.7%) from their portfolio in Q4 2025, for an estimated $62,718,810
- BARCLAYS PLC added 7,200,508 shares (+305.0%) to their portfolio in Q4 2025, for an estimated $55,947,947
- PRICE T ROWE ASSOCIATES INC /MD/ added 7,082,560 shares (+737.3%) to their portfolio in Q4 2025, for an estimated $55,031,491
- CONTOUR ASSET MANAGEMENT LLC removed 4,970,793 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $38,623,061
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
LUMN Price Targets
Multiple analysts have issued price targets for $LUMN recently. We have seen 4 analysts offer price targets for $LUMN in the last 6 months, with a median target of $7.625.
Here are some recent targets:
- Batya Levi from UBS set a target price of $6.0 on 02/05/2026
- Michael Rollins from Citigroup set a target price of $10.0 on 02/05/2026
- Michael Ng from Goldman Sachs set a target price of $7.25 on 02/04/2026
- Jonathan Atkin from RBC Capital set a target price of $8.0 on 11/25/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$60,000 of NETFLIX INC. lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"The proposed Netflix/Warner Bros. transaction, and related competition issues"
You can find more data on corporate lobbying on Quiver Quantitative.
NFLX Congressional Stock Trading
Members of Congress have traded $NFLX stock 20 times in the past 6 months. Of those trades, 13 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $NFLX stock by members of Congress over the last 6 months:
- SENATOR ANGUS S. KING JR. sold up to $15,000 on 02/13.
- REPRESENTATIVE CLEO FIELDS has traded it 8 times. They made 8 purchases worth up to $1,380,000 on 01/20, 12/03, 11/20, 11/03, 10/31 and 0 sales.
- SENATOR JOHN BOOZMAN purchased up to $15,000 on 01/08.
- REPRESENTATIVE RICK W. ALLEN sold up to $15,000 on 12/12.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 4 times. They made 2 purchases worth up to $30,000 on 11/18, 10/17 and 2 sales worth up to $30,000 on 12/10, 10/07.
- REPRESENTATIVE JONATHAN L. JACKSON sold up to $100,000 on 12/08.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
- REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $15,000 on 10/24.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
NFLX Insider Trading Activity
NFLX insiders have traded $NFLX stock on the open market 121 times in the past 6 months. Of those trades, 0 have been purchases and 121 have been sales.
Here’s a breakdown of recent trading of $NFLX stock by insiders over the last 6 months:
- REED HASTINGS has made 0 purchases and 54 sales selling 1,685,830 shares for an estimated $247,020,841.
- DAVID A HYMAN (Chief Legal Officer) has made 0 purchases and 4 sales selling 60,628 shares for an estimated $37,132,628.
- SPENCER ADAM NEUMANN (Chief Financial Officer) has made 0 purchases and 51 sales selling 101,033 shares for an estimated $15,665,181.
- GREGORY K PETERS (Co-CEO) has made 0 purchases and 6 sales selling 135,120 shares for an estimated $13,267,425.
- BRADFORD L SMITH has made 0 purchases and 3 sales selling 31,790 shares for an estimated $2,824,821.
- THEODORE A SARANDOS (Co-CEO) sold 2,027 shares for an estimated $2,213,638
- CLETUS R WILLEMS (Chief Global Affairs Officer) has made 0 purchases and 2 sales selling 3,374 shares for an estimated $521,131.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
NFLX Hedge Fund Activity
We have seen 1,679 institutional investors add shares of NFLX stock to their portfolio, and 1,641 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 77,868,029 shares (-70.9%) from their portfolio in Q4 2025, for an estimated $7,300,906,399
- NORGES BANK added 61,894,705 shares (+inf%) to their portfolio in Q4 2025, for an estimated $5,803,247,540
- BANK OF NEW YORK MELLON CORP removed 28,686,390 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $2,689,635,926
- JPMORGAN CHASE & CO removed 25,714,908 shares (-28.8%) from their portfolio in Q4 2025, for an estimated $2,411,029,774
- PRICE T ROWE ASSOCIATES INC /MD/ removed 23,459,212 shares (-21.4%) from their portfolio in Q4 2025, for an estimated $2,199,535,717
- FMR LLC removed 15,207,723 shares (-7.2%) from their portfolio in Q4 2025, for an estimated $1,425,876,108
- JENNISON ASSOCIATES LLC removed 12,258,559 shares (-26.0%) from their portfolio in Q4 2025, for an estimated $1,149,362,491
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
NFLX Analyst Ratings
Wall Street analysts have issued reports on $NFLX in the last several months. We have seen 16 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wolfe Research issued a "Outperform" rating on 01/21/2026
- Piper Sandler issued a "Overweight" rating on 01/21/2026
- TD Cowen issued a "Buy" rating on 01/21/2026
- Oppenheimer issued a "Outperform" rating on 01/21/2026
- Guggenheim issued a "Buy" rating on 01/21/2026
- Morgan Stanley issued a "Overweight" rating on 01/21/2026
- BMO Capital issued a "Outperform" rating on 01/21/2026
To track analyst ratings and price targets for NFLX, check out Quiver Quantitative's $NFLX forecast page.
NFLX Price Targets
Multiple analysts have issued price targets for $NFLX recently. We have seen 29 analysts offer price targets for $NFLX in the last 6 months, with a median target of $115.0.
Here are some recent targets:
- Jason Helfstein from Oppenheimer set a target price of $135.0 on 03/27/2026
- Jason Bazinet from Citigroup set a target price of $115.0 on 03/18/2026
- Steven Cahall from Wells Fargo set a target price of $105.0 on 03/09/2026
- Jessica Reif Ehrlich from B of A Securities set a target price of $125.0 on 03/06/2026
- Kenneth Leon from CFRA set a target price of $115.0 on 03/06/2026
- Kannan Venkateshwar from Barclays set a target price of $115.0 on 03/02/2026
- Doug Anmuth from JP Morgan set a target price of $120.0 on 03/02/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$40,000 of BG WORKFORCE lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Workforce Training Systems"
You can find more data on corporate lobbying on Quiver Quantitative.
KFRC Hedge Fund Activity
We have seen 112 institutional investors add shares of KFRC stock to their portfolio, and 90 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TRIBUTARY CAPITAL MANAGEMENT, LLC removed 449,331 shares (-54.3%) from their portfolio in Q4 2025, for an estimated $13,893,314
- FMR LLC removed 388,002 shares (-93.4%) from their portfolio in Q4 2025, for an estimated $11,997,021
- VANGUARD GROUP INC removed 344,776 shares (-23.7%) from their portfolio in Q4 2025, for an estimated $10,660,473
- BLACKROCK, INC. added 292,957 shares (+19.3%) to their portfolio in Q4 2025, for an estimated $9,058,230
- KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC removed 250,465 shares (-11.2%) from their portfolio in Q4 2025, for an estimated $7,744,377
- AQR CAPITAL MANAGEMENT LLC added 198,447 shares (+81.3%) to their portfolio in Q4 2025, for an estimated $6,135,981
- UBS GROUP AG removed 197,903 shares (-88.3%) from their portfolio in Q4 2025, for an estimated $6,119,160
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
KFRC Price Targets
Multiple analysts have issued price targets for $KFRC recently. We have seen 2 analysts offer price targets for $KFRC in the last 6 months, with a median target of $38.5.
Here are some recent targets:
- Joshua Chan from UBS set a target price of $39.0 on 02/03/2026
- Tobey Sommer from Truist Securities set a target price of $38.0 on 01/27/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$40,000 of HEWLETT PACKARD ENTERPRISE COMPANY lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to corporate and international tax. Issues related to OECD Pillar 1 and Pillar 2 negotiations and agreements on the taxation of global income and the potential impacts on the tax base of the U.S. and its Territories. Issues related to IRC sections 11, 163(j), 174, and 951A."
You can find more data on corporate lobbying on Quiver Quantitative.
HPE Congressional Stock Trading
Members of Congress have traded $HPE stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $HPE stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
HPE Insider Trading Activity
HPE insiders have traded $HPE stock on the open market 17 times in the past 6 months. Of those trades, 0 have been purchases and 17 have been sales.
Here’s a breakdown of recent trading of $HPE stock by insiders over the last 6 months:
- ANTONIO F NERI (President and CEO) has made 0 purchases and 3 sales selling 290,889 shares for an estimated $7,306,481.
- JOHN F SCHULTZ (EVP, COLO) has made 0 purchases and 3 sales selling 254,184 shares for an estimated $6,168,310.
- FIDELMA RUSSO (EVP, GM, Hybrid Cloud & CTO) has made 0 purchases and 3 sales selling 160,513 shares for an estimated $3,966,003.
- NEIL B MACDONALD (EVP, GM, Server) has made 0 purchases and 2 sales selling 112,652 shares for an estimated $2,826,604.
- JEREMY COX (SVP, Controller & CTO) has made 0 purchases and 3 sales selling 76,966 shares for an estimated $1,851,455.
- KIRT P KARROS (SVP, Treasurer, Corp Dev) sold 36,460 shares for an estimated $897,167
- MAEVE C CULLOTY (EVP, Pres & CEO Financial Serv) sold 35,958 shares for an estimated $886,562
- JEAN M. HOBBY sold 29,000 shares for an estimated $689,968
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
HPE Hedge Fund Activity
We have seen 494 institutional investors add shares of HPE stock to their portfolio, and 479 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 39,383,491 shares (-74.9%) from their portfolio in Q4 2025, for an estimated $945,991,453
- CAPITAL WORLD INVESTORS added 37,541,672 shares (+inf%) to their portfolio in Q4 2025, for an estimated $901,750,961
- BARROW HANLEY MEWHINNEY & STRAUSS LLC added 18,049,010 shares (+inf%) to their portfolio in Q4 2025, for an estimated $433,537,220
- BANK OF AMERICA CORP /DE/ added 17,336,750 shares (+31.6%) to their portfolio in Q4 2025, for an estimated $416,428,735
- JERICHO CAPITAL ASSET MANAGEMENT L.P. removed 16,974,768 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $407,733,927
- POINT72 ASSET MANAGEMENT, L.P. removed 11,565,283 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $277,798,097
- D. E. SHAW & CO., INC. added 11,259,326 shares (+478.4%) to their portfolio in Q4 2025, for an estimated $270,449,010
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
HPE Analyst Ratings
Wall Street analysts have issued reports on $HPE in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BWG Global issued a "Positive" rating on 11/24/2025
To track analyst ratings and price targets for HPE, check out Quiver Quantitative's $HPE forecast page.
HPE Price Targets
Multiple analysts have issued price targets for $HPE recently. We have seen 10 analysts offer price targets for $HPE in the last 6 months, with a median target of $28.5.
Here are some recent targets:
- Matthew Niknam from Truist Securities set a target price of $31.0 on 03/31/2026
- Amit Daryanani from Evercore ISI Group set a target price of $30.0 on 03/26/2026
- Asiya Merchant from Citigroup set a target price of $27.0 on 03/11/2026
- Meta Marshall from Morgan Stanley set a target price of $25.0 on 03/10/2026
- Wamsi Mohan from B of A Securities set a target price of $32.0 on 03/10/2026
- Jim Kelleher from Argus Research set a target price of $30.0 on 12/10/2025
- James Fish from Piper Sandler set a target price of $24.0 on 10/22/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$30,000 of FEDEX CORPORATION lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to China trade policy. Trade and customs issues related to low-value shipments. (H.R. 7224) Issues related to corporate and international taxation, including IRC sections 11, 51, and 951A. Issues related to OECD Pillar 1 and Pillar 2 negotiations and agreements on the taxation of global income."
You can find more data on corporate lobbying on Quiver Quantitative.
FDX Congressional Stock Trading
Members of Congress have traded $FDX stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $FDX stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 01/09.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
FDX Hedge Fund Activity
We have seen 800 institutional investors add shares of FDX stock to their portfolio, and 743 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 4,071,468 shares (-75.3%) from their portfolio in Q4 2025, for an estimated $1,176,084,246
- FMR LLC added 2,053,626 shares (+69.5%) to their portfolio in Q4 2025, for an estimated $593,210,406
- PRIMECAP MANAGEMENT CO/CA/ removed 929,579 shares (-9.8%) from their portfolio in Q4 2025, for an estimated $268,518,189
- BALYASNY ASSET MANAGEMENT L.P. added 745,703 shares (+27008.4%) to their portfolio in Q4 2025, for an estimated $215,403,768
- WADDELL & ASSOCIATES, LLC added 738,122 shares (+164.0%) to their portfolio in Q4 2025, for an estimated $213,213,920
- CAPITAL INTERNATIONAL INVESTORS removed 685,766 shares (-15.9%) from their portfolio in Q4 2025, for an estimated $198,090,366
- DODGE & COX removed 642,992 shares (-4.0%) from their portfolio in Q4 2025, for an estimated $185,734,669
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
FDX Analyst Ratings
Wall Street analysts have issued reports on $FDX in the last several months. We have seen 5 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Jefferies issued a "Buy" rating on 12/19/2025
- Stifel issued a "Buy" rating on 12/19/2025
- Stephens & Co. issued a "Overweight" rating on 12/19/2025
- Truist Securities issued a "Buy" rating on 12/19/2025
- Morgan Stanley issued a "Underweight" rating on 12/19/2025
- Citigroup issued a "Buy" rating on 12/19/2025
To track analyst ratings and price targets for FDX, check out Quiver Quantitative's $FDX forecast page.
FDX Price Targets
Multiple analysts have issued price targets for $FDX recently. We have seen 18 analysts offer price targets for $FDX in the last 6 months, with a median target of $417.5.
Here are some recent targets:
- Brian Ossenbeck from JP Morgan set a target price of $432.0 on 03/20/2026
- Lucas Servera from Truist Securities set a target price of $425.0 on 03/20/2026
- Christian Wetherbee from Wells Fargo set a target price of $450.0 on 03/20/2026
- Ravi Shanker from Morgan Stanley set a target price of $230.0 on 03/20/2026
- Ken Hoexter from B of A Securities set a target price of $440.0 on 03/20/2026
- J. Bruce Chan from Stifel set a target price of $425.0 on 03/20/2026
- Reed Seay from Stephens & Co. set a target price of $435.0 on 03/20/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$30,000 of LEGGETT & PLATT INC. lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to corporate and international tax. Issues related IRC sections 11, 951A, 174, and 163(j). Issues related to foreign country tax administration."
You can find more data on corporate lobbying on Quiver Quantitative.
LEG Hedge Fund Activity
We have seen 162 institutional investors add shares of LEG stock to their portfolio, and 152 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- NORGES BANK removed 1,200,200 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $13,202,200
- D. E. SHAW & CO., INC. removed 1,188,944 shares (-39.8%) from their portfolio in Q4 2025, for an estimated $13,078,384
- PACER ADVISORS, INC. removed 1,149,737 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $12,647,107
- M&T BANK CORP added 1,118,707 shares (+8333.0%) to their portfolio in Q4 2025, for an estimated $12,305,777
- LAZARD ASSET MANAGEMENT LLC added 1,026,959 shares (+inf%) to their portfolio in Q4 2025, for an estimated $11,296,549
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 981,447 shares (-74.8%) from their portfolio in Q4 2025, for an estimated $10,795,917
- TOWLE & CO added 953,080 shares (+inf%) to their portfolio in Q4 2025, for an estimated $10,483,880
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
LEG Price Targets
Multiple analysts have issued price targets for $LEG recently. We have seen 2 analysts offer price targets for $LEG in the last 6 months, with a median target of $12.0.
Here are some recent targets:
- Peter Keith from Piper Sandler set a target price of $12.0 on 12/11/2025
- Keith Hughes from Truist Securities set a target price of $12.0 on 10/29/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$20,000 of VIASAT INC. lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Advocated on issues related to satellite communications, specifically the value of satellite services"
You can find more data on corporate lobbying on Quiver Quantitative.
VSAT Congressional Stock Trading
Members of Congress have traded $VSAT stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $VSAT stock by members of Congress over the last 6 months:
- REPRESENTATIVE JONATHAN L. JACKSON purchased up to $100,000 on 01/22.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
VSAT Insider Trading Activity
VSAT insiders have traded $VSAT stock on the open market 19 times in the past 6 months. Of those trades, 0 have been purchases and 19 have been sales.
Here’s a breakdown of recent trading of $VSAT stock by insiders over the last 6 months:
- MARK D DANKBERG (Chairman and CEO) has made 0 purchases and 4 sales selling 300,000 shares for an estimated $11,052,173.
- SHAWN LYNN DUFFY (SVP, Chief Accounting Officer) has made 0 purchases and 2 sales selling 51,480 shares for an estimated $1,873,022.
- CRAIG ANDREW MILLER (SVP, Pres Viasat Government) has made 0 purchases and 3 sales selling 40,645 shares for an estimated $1,856,317.
- ROBERT JAMES BLAIR (SVP, General Counsel) has made 0 purchases and 3 sales selling 32,680 shares for an estimated $1,511,456.
- GARRETT L. CHASE (SVP, Chief Financial Officer) has made 0 purchases and 4 sales selling 25,000 shares for an estimated $872,636.
- BENJAMIN EDWARD PALMER (SVP, Pres Commercial) has made 0 purchases and 2 sales selling 5,180 shares for an estimated $211,164.
- CAMELLIA E FITZGERALD (Chief Accounting Officer) sold 2,810 shares for an estimated $134,880
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
VSAT Hedge Fund Activity
We have seen 186 institutional investors add shares of VSAT stock to their portfolio, and 140 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CANADA PENSION PLAN INVESTMENT BOARD removed 4,789,434 shares (-99.9%) from their portfolio in Q4 2025, for an estimated $165,043,895
- PRICE T ROWE ASSOCIATES INC /MD/ added 3,112,670 shares (+2821.7%) to their portfolio in Q4 2025, for an estimated $107,262,608
- MORGAN STANLEY removed 1,303,929 shares (-46.9%) from their portfolio in Q4 2025, for an estimated $44,933,393
- JANE STREET GROUP, LLC added 1,261,895 shares (+3459.0%) to their portfolio in Q4 2025, for an estimated $43,484,901
- ROYAL BANK OF CANADA removed 996,771 shares (-89.8%) from their portfolio in Q4 2025, for an estimated $34,348,728
- AMERICAN CENTURY COMPANIES INC added 917,644 shares (+24.7%) to their portfolio in Q4 2025, for an estimated $31,622,012
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 772,026 shares (-74.7%) from their portfolio in Q4 2025, for an estimated $26,604,015
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
VSAT Price Targets
Multiple analysts have issued price targets for $VSAT recently. We have seen 3 analysts offer price targets for $VSAT in the last 6 months, with a median target of $50.0.
Here are some recent targets:
- Ryan Koontz from Needham set a target price of $58.0 on 03/27/2026
- Edison Yu from Deutsche Bank set a target price of $48.0 on 02/09/2026
- Philip Cusick from JP Morgan set a target price of $50.0 on 11/11/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$20,000 of 8X8 INC. lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues pertaining to Universal Service Fund (USF) reform."
You can find more data on corporate lobbying on Quiver Quantitative.
EGHT Insider Trading Activity
EGHT insiders have traded $EGHT stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $EGHT stock by insiders over the last 6 months:
- HUNTER MIDDLETON (Chief Product Officer) sold 85,044 shares for an estimated $212,814
- LAURENCE DENNY (Chief Legal Officer) has made 0 purchases and 2 sales selling 10,000 shares for an estimated $22,491.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
EGHT Hedge Fund Activity
We have seen 93 institutional investors add shares of EGHT stock to their portfolio, and 54 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SYLEBRA CAPITAL LLC removed 2,283,446 shares (-16.6%) from their portfolio in Q4 2025, for an estimated $4,498,388
- BOSTON PARTNERS removed 1,398,708 shares (-16.3%) from their portfolio in Q4 2025, for an estimated $2,755,454
- NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO added 1,093,089 shares (+1093089.0%) to their portfolio in Q4 2025, for an estimated $2,153,385
- S SQUARED TECHNOLOGY, LLC removed 484,806 shares (-34.2%) from their portfolio in Q4 2025, for an estimated $955,067
- MARSHALL WACE, LLP added 480,477 shares (+314.6%) to their portfolio in Q4 2025, for an estimated $946,539
- AQR CAPITAL MANAGEMENT LLC added 441,157 shares (+14.9%) to their portfolio in Q4 2025, for an estimated $869,079
- BANK OF AMERICA CORP /DE/ added 410,610 shares (+6.6%) to their portfolio in Q4 2025, for an estimated $808,901
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
EGHT Analyst Ratings
Wall Street analysts have issued reports on $EGHT in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Rosenblatt issued a "Buy" rating on 11/05/2025
To track analyst ratings and price targets for EGHT, check out Quiver Quantitative's $EGHT forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$10,000 of CNO FINANCIAL GROUP lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"None"
You can find more data on corporate lobbying on Quiver Quantitative.
CNO Insider Trading Activity
CNO insiders have traded $CNO stock on the open market 16 times in the past 6 months. Of those trades, 0 have been purchases and 16 have been sales.
Here’s a breakdown of recent trading of $CNO stock by insiders over the last 6 months:
- GARY C. BHOJWANI (Chief Executive Officer) has made 0 purchases and 4 sales selling 151,238 shares for an estimated $6,385,948.
- MATTHEW J. ZIMPFER (General Counsel) has made 0 purchases and 3 sales selling 88,340 shares for an estimated $3,802,136.
- ERIC R. JOHNSON (Chief Investment Officer) sold 48,665 shares for an estimated $2,007,012
- SCOTT L. GOLDBERG (President, Consumer Division) has made 0 purchases and 2 sales selling 22,120 shares for an estimated $879,423.
- YVONNE K. FRANZESE (Chief Human Resources Officer) has made 0 purchases and 4 sales selling 12,000 shares for an estimated $511,556.
- ROCCO F III TARASI (Chief Marketing Officer) has made 0 purchases and 2 sales selling 9,283 shares for an estimated $395,438.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CNO Hedge Fund Activity
We have seen 152 institutional investors add shares of CNO stock to their portfolio, and 198 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MACQUARIE GROUP LTD removed 2,365,602 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $100,467,116
- M&T BANK CORP added 920,001 shares (+inf%) to their portfolio in Q4 2025, for an estimated $39,072,442
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 803,920 shares (-76.6%) from their portfolio in Q4 2025, for an estimated $34,142,482
- HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND added 430,820 shares (+inf%) to their portfolio in Q4 2025, for an estimated $18,296,925
- VANGUARD GROUP INC removed 426,328 shares (-3.5%) from their portfolio in Q4 2025, for an estimated $18,106,150
- JAIN GLOBAL LLC added 423,741 shares (+inf%) to their portfolio in Q4 2025, for an estimated $17,996,280
- MILLENNIUM MANAGEMENT LLC removed 418,028 shares (-72.1%) from their portfolio in Q4 2025, for an estimated $17,753,649
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CNO Analyst Ratings
Wall Street analysts have issued reports on $CNO in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 12/23/2025
To track analyst ratings and price targets for CNO, check out Quiver Quantitative's $CNO forecast page.
CNO Price Targets
Multiple analysts have issued price targets for $CNO recently. We have seen 4 analysts offer price targets for $CNO in the last 6 months, with a median target of $46.5.
Here are some recent targets:
- Ryan Krueger from Keefe, Bruyette & Woods set a target price of $46.0 on 03/26/2026
- Thomas Gallagher from Evercore ISI Group set a target price of $43.0 on 02/18/2026
- John Barnidge from Piper Sandler set a target price of $50.0 on 12/23/2025
- Suneet Kamath from Jefferies set a target price of $47.0 on 12/15/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$45,000 of OLD DOMINION FREIGHT LINE INC. lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Transportation"
You can find more data on corporate lobbying on Quiver Quantitative.
ODFL Congressional Stock Trading
Members of Congress have traded $ODFL stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $ODFL stock by members of Congress over the last 6 months:
- REPRESENTATIVE RICK LARSEN sold up to $15,000 on 10/06.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
ODFL Insider Trading Activity
ODFL insiders have traded $ODFL stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $ODFL stock by insiders over the last 6 months:
- DAVID S CONGDON (Executive Chairman) has made 0 purchases and 2 sales selling 52,000 shares for an estimated $10,127,839.
- GREG C GANTT sold 12,024 shares for an estimated $2,361,874
- BRADLEY R GABOSCH sold 3,134 shares for an estimated $608,842
- CHRISTOPHER JAMES KELLEY (SVP - Operations) sold 80 shares for an estimated $16,034
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ODFL Hedge Fund Activity
We have seen 472 institutional investors add shares of ODFL stock to their portfolio, and 516 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 5,109,768 shares (+288.4%) to their portfolio in Q4 2025, for an estimated $801,211,622
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 3,403,605 shares (-78.0%) from their portfolio in Q4 2025, for an estimated $533,685,264
- BOSTON PARTNERS added 2,044,434 shares (+98.4%) to their portfolio in Q4 2025, for an estimated $320,567,251
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,761,511 shares (+14.1%) to their portfolio in Q4 2025, for an estimated $276,204,924
- AMERIPRISE FINANCIAL INC removed 1,246,482 shares (-83.1%) from their portfolio in Q4 2025, for an estimated $195,448,377
- LAZARD ASSET MANAGEMENT LLC removed 1,186,192 shares (-57.7%) from their portfolio in Q4 2025, for an estimated $185,994,905
- FRANKLIN RESOURCES INC added 1,004,609 shares (+122.9%) to their portfolio in Q4 2025, for an estimated $157,522,691
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ODFL Analyst Ratings
Wall Street analysts have issued reports on $ODFL in the last several months. We have seen 6 firms issue buy ratings on the stock, and 2 firms issue sell ratings.
Here are some recent analyst ratings:
- Baird issued a "Underperform" rating on 02/05/2026
- Stifel issued a "Buy" rating on 01/21/2026
- Truist Securities issued a "Buy" rating on 01/15/2026
- BMO Capital issued a "Outperform" rating on 12/01/2025
- Stephens & Co. issued a "Overweight" rating on 10/30/2025
- Raymond James issued a "Outperform" rating on 10/30/2025
- Wells Fargo issued a "Underweight" rating on 10/30/2025
To track analyst ratings and price targets for ODFL, check out Quiver Quantitative's $ODFL forecast page.
ODFL Price Targets
Multiple analysts have issued price targets for $ODFL recently. We have seen 18 analysts offer price targets for $ODFL in the last 6 months, with a median target of $183.5.
Here are some recent targets:
- Jonathan Chappell from Evercore ISI Group set a target price of $201.0 on 03/27/2026
- Brian Ossenbeck from JP Morgan set a target price of $182.0 on 03/10/2026
- Bascome Majors from Susquehanna set a target price of $205.0 on 02/11/2026
- Ariel Rosa from Citigroup set a target price of $216.0 on 02/09/2026
- Ravi Shanker from Morgan Stanley set a target price of $209.0 on 02/05/2026
- Daniel Moore from Baird set a target price of $204.0 on 02/05/2026
- Stephanie Moore from Jefferies set a target price of $195.0 on 02/05/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$45,000 of WERNER ENTERPRISES lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Transportation"
You can find more data on corporate lobbying on Quiver Quantitative.
WERN Insider Trading Activity
WERN insiders have traded $WERN stock on the open market 16 times in the past 6 months. Of those trades, 14 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $WERN stock by insiders over the last 6 months:
- ERIC J DOWNING (Exec VP and COO) has made 2 purchases buying 259 shares for an estimated $6,902 and 2 sales selling 2,846 shares for an estimated $99,292.
- DEREK J LEATHERS (CEO & Chairman) has made 2 purchases buying 309 shares for an estimated $8,359 and 0 sales.
- JIM S SCHELBLE (Exec VP & Chief Admin Officer) has made 2 purchases buying 294 shares for an estimated $7,911 and 0 sales.
- NATHAN J MEISGEIER (President and CLO) has made 2 purchases buying 277 shares for an estimated $7,432 and 0 sales.
- CRAIG T CALLAHAN (Exec VP-Chief Commercial Offcr) has made 2 purchases buying 253 shares for an estimated $6,729 and 0 sales.
- DARAGH P MAHON (Executive Vice President & CIO) has made 2 purchases buying 241 shares for an estimated $6,377 and 0 sales.
- JAMES LYNN JOHNSON (Exec VP - Chief Acctg Officer) has made 2 purchases buying 230 shares for an estimated $6,064 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
WERN Hedge Fund Activity
We have seen 109 institutional investors add shares of WERN stock to their portfolio, and 166 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FIRST TRUST ADVISORS LP removed 2,927,439 shares (-95.7%) from their portfolio in Q4 2025, for an estimated $87,852,444
- MACQUARIE GROUP LTD removed 2,204,819 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $66,166,618
- WELLINGTON MANAGEMENT GROUP LLP added 2,154,428 shares (+605.3%) to their portfolio in Q4 2025, for an estimated $64,654,384
- INVESCO LTD. added 1,409,556 shares (+539.7%) to their portfolio in Q4 2025, for an estimated $42,300,775
- VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. added 1,139,653 shares (+inf%) to their portfolio in Q4 2025, for an estimated $34,200,986
- BALYASNY ASSET MANAGEMENT L.P. added 1,104,160 shares (+572.4%) to their portfolio in Q4 2025, for an estimated $33,135,841
- MAPLE ROCK CAPITAL PARTNERS INC. added 793,500 shares (+inf%) to their portfolio in Q4 2025, for an estimated $23,812,935
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
WERN Analyst Ratings
Wall Street analysts have issued reports on $WERN in the last several months. We have seen 0 firms issue buy ratings on the stock, and 2 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Underweight" rating on 10/31/2025
- Wells Fargo issued a "Underweight" rating on 10/06/2025
To track analyst ratings and price targets for WERN, check out Quiver Quantitative's $WERN forecast page.
WERN Price Targets
Multiple analysts have issued price targets for $WERN recently. We have seen 11 analysts offer price targets for $WERN in the last 6 months, with a median target of $31.0.
Here are some recent targets:
- Jonathan Chappell from Evercore ISI Group set a target price of $29.0 on 03/27/2026
- Ariel Rosa from Citigroup set a target price of $34.0 on 03/09/2026
- Thomas Wadewitz from UBS set a target price of $33.0 on 02/10/2026
- Brian Ossenbeck from JP Morgan set a target price of $28.0 on 02/06/2026
- Christian Wetherbee from Wells Fargo set a target price of $39.0 on 02/06/2026
- Jason H. Seidl from TD Cowen set a target price of $31.0 on 01/30/2026
- Brandon Oglenski from Barclays set a target price of $33.0 on 01/15/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$175,000 of TRINET GROUP INC. lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to the Research and Development Tax Credit. Discussed efforts to reduce the employee retention tax credit (ERTC) payroll processing backlog. - H.R. 3223 Educate Members of Congress on professional employee organizations (PEOs); advocate for PEOs to continue to provide human resource benefits to small- and medium-size business. General educational discussions on employer-sponsored health insurance and employee access to health insurance through employment."
You can find more data on corporate lobbying on Quiver Quantitative.
TNET Insider Trading Activity
TNET insiders have traded $TNET stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $TNET stock by insiders over the last 6 months:
- SIDNEY A. MAJALYA (SVP, CLO and Secretary) has made 0 purchases and 2 sales selling 1,550 shares for an estimated $99,037.
- JEFFERY JON HAYWARD (Chief Technology Officer) has made 0 purchases and 2 sales selling 1,564 shares for an estimated $89,626.
- ANTHONY SHEA TREADWAY (SVP, Chief Revenue Officer) has made 0 purchases and 2 sales selling 946 shares for an estimated $45,386.
- PAUL EDWARD CHAMBERLAIN sold 600 shares for an estimated $34,686
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
TNET Hedge Fund Activity
We have seen 123 institutional investors add shares of TNET stock to their portfolio, and 171 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MAWER INVESTMENT MANAGEMENT LTD. removed 2,806,573 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $187,731,667
- VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. removed 715,840 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $42,327,619
- NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO added 709,339 shares (+5911158.3%) to their portfolio in Q4 2025, for an estimated $41,943,215
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 663,121 shares (-28.2%) from their portfolio in Q4 2025, for an estimated $39,210,344
- MILLENNIUM MANAGEMENT LLC added 427,242 shares (+1047.5%) to their portfolio in Q4 2025, for an estimated $25,262,819
- NORGES BANK added 392,576 shares (+459.4%) to their portfolio in Q4 2025, for an estimated $23,213,018
- POINT72 ASSET MANAGEMENT, L.P. added 391,647 shares (+82.7%) to their portfolio in Q4 2025, for an estimated $23,158,087
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
TNET Analyst Ratings
Wall Street analysts have issued reports on $TNET in the last several months. We have seen 0 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Underweight" rating on 10/30/2025
To track analyst ratings and price targets for TNET, check out Quiver Quantitative's $TNET forecast page.
TNET Price Targets
Multiple analysts have issued price targets for $TNET recently. We have seen 5 analysts offer price targets for $TNET in the last 6 months, with a median target of $64.0.
Here are some recent targets:
- David Grossman from Stifel set a target price of $75.0 on 02/13/2026
- Jared Levine from TD Cowen set a target price of $64.0 on 01/08/2026
- Tobey Sommer from Truist Securities set a target price of $62.0 on 12/05/2025
- Kevin Mcveigh from UBS set a target price of $63.0 on 10/30/2025
- Tien-Tsin Huang from JP Morgan set a target price of $65.0 on 10/30/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$10,000 of MERIT MEDICAL SYSTEMS INC. lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Tariffs, corporate tax Reimbursement, MCIT International trade, supply chain"
You can find more data on corporate lobbying on Quiver Quantitative.
MMSI Insider Trading Activity
MMSI insiders have traded $MMSI stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $MMSI stock by insiders over the last 6 months:
- FRED P. LAMPROPOULOS (Executive Chairman) has made 0 purchases and 4 sales selling 60,000 shares for an estimated $5,189,907.
- NEIL W. PETERSON (CHIEF OPERATING OFFICER) sold 5,000 shares for an estimated $450,000
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
MMSI Hedge Fund Activity
We have seen 228 institutional investors add shares of MMSI stock to their portfolio, and 198 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MACQUARIE GROUP LTD removed 1,331,579 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $117,365,373
- MAVERICK CAPITAL LTD removed 1,124,048 shares (-69.8%) from their portfolio in Q4 2025, for an estimated $99,073,590
- CITIGROUP INC added 1,035,584 shares (+4390.9%) to their portfolio in Q4 2025, for an estimated $91,276,373
- LOOMIS SAYLES & CO L P removed 447,381 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $39,432,161
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 440,026 shares (-74.3%) from their portfolio in Q4 2025, for an estimated $38,783,891
- POINT72 ASSET MANAGEMENT, L.P. added 436,531 shares (+inf%) to their portfolio in Q4 2025, for an estimated $38,475,842
- FRANKLIN RESOURCES INC removed 423,618 shares (-50.4%) from their portfolio in Q4 2025, for an estimated $37,337,690
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
MMSI Analyst Ratings
Wall Street analysts have issued reports on $MMSI in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 02/18/2026
- Needham issued a "Buy" rating on 01/09/2026
- Wells Fargo issued a "Overweight" rating on 11/14/2025
- Canaccord Genuity issued a "Buy" rating on 11/14/2025
- Barrington Research issued a "Outperform" rating on 11/14/2025
To track analyst ratings and price targets for MMSI, check out Quiver Quantitative's $MMSI forecast page.
MMSI Price Targets
Multiple analysts have issued price targets for $MMSI recently. We have seen 6 analysts offer price targets for $MMSI in the last 6 months, with a median target of $103.5.
Here are some recent targets:
- Larry Biegelsen from Wells Fargo set a target price of $78.0 on 02/26/2026
- Mike Matson from Needham set a target price of $101.0 on 02/25/2026
- Michael Petusky from Barrington Research set a target price of $109.0 on 02/25/2026
- Jason Bednar from Piper Sandler set a target price of $106.0 on 02/18/2026
- Sam Eiber from BTIG set a target price of $107.0 on 02/06/2026
- Jon Young from Canaccord Genuity set a target price of $99.0 on 12/17/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$60,000 of JPMORGAN CHASE HOLDINGS LLC lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues regarding tax, budget, regulatory reform, general financial services issues;"
You can find more data on corporate lobbying on Quiver Quantitative.
JPM Congressional Stock Trading
Members of Congress have traded $JPM stock 11 times in the past 6 months. Of those trades, 8 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $JPM stock by members of Congress over the last 6 months:
- REPRESENTATIVE DAVID TAYLOR has traded it 2 times. They made 2 purchases worth up to $30,000 on 01/29 and 0 sales.
- SENATOR KATIE BOYD BRITT sold up to $15,000 on 01/28.
- REPRESENTATIVE JONATHAN L. JACKSON purchased up to $15,000 on 01/20.
- SENATOR MARKWAYNE MULLIN purchased up to $100,000 on 12/29.
- REPRESENTATIVE ROGER WILLIAMS purchased up to $15,000 on 12/22.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 2 purchases worth up to $30,000 on 11/18, 10/17 and 0 sales.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
JPM Insider Trading Activity
JPM insiders have traded $JPM stock on the open market 24 times in the past 6 months. Of those trades, 0 have been purchases and 24 have been sales.
Here’s a breakdown of recent trading of $JPM stock by insiders over the last 6 months:
- JAMES DIMON (Chairman & CEO) has made 0 purchases and 6 sales selling 69,512 shares for an estimated $21,353,561.
- TROY L ROHRBAUGH (Co-CEO CIB) sold 50,000 shares for an estimated $15,355,670
- MARY E. ERDOES (CEO Asset & Wealth Management) has made 0 purchases and 2 sales selling 11,463 shares for an estimated $3,548,924.
- JENNIFER PIEPSZAK (Chief Operating Officer) sold 8,571 shares for an estimated $2,680,887
- MARIANNE LAKE (CEO CCB) has made 0 purchases and 2 sales selling 7,815 shares for an estimated $2,419,511.
- ASHLEY BACON (Chief Risk Officer) sold 7,364 shares for an estimated $2,303,392
- DOUGLAS B PETNO (Co-CEO CIB) has made 0 purchases and 2 sales selling 6,974 shares for an estimated $2,159,156.
- STACEY FRIEDMAN (General Counsel) has made 0 purchases and 2 sales selling 6,808 shares for an estimated $2,107,743.
- JEREMY BARNUM (Chief Financial Officer) has made 0 purchases and 2 sales selling 5,785 shares for an estimated $1,791,046.
- LORI A BEER (Chief Information Officer) has made 0 purchases and 2 sales selling 4,094 shares for an estimated $1,267,502.
- ROBIN LEOPOLD (Head of Human Resources) has made 0 purchases and 3 sales selling 1,831 shares for an estimated $561,756.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
JPM Hedge Fund Activity
We have seen 2,121 institutional investors add shares of JPM stock to their portfolio, and 2,343 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 50,135,205 shares (-75.3%) from their portfolio in Q4 2025, for an estimated $16,154,565,755
- CARDANO RISK MANAGEMENT B.V. added 7,796,814 shares (+889.3%) to their portfolio in Q4 2025, for an estimated $2,512,289,407
- CORIENT PRIVATE WEALTH LLC added 6,322,131 shares (+197.9%) to their portfolio in Q4 2025, for an estimated $2,037,117,050
- SG AMERICAS SECURITIES, LLC added 6,215,423 shares (+223496.0%) to their portfolio in Q4 2025, for an estimated $2,002,733,599
- CAPITAL WORLD INVESTORS removed 5,954,212 shares (-24.7%) from their portfolio in Q4 2025, for an estimated $1,918,566,190
- BARCLAYS PLC removed 4,312,292 shares (-30.7%) from their portfolio in Q4 2025, for an estimated $1,389,506,728
- WELLINGTON MANAGEMENT GROUP LLP removed 3,425,119 shares (-24.8%) from their portfolio in Q4 2025, for an estimated $1,103,641,844
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
JPM Analyst Ratings
Wall Street analysts have issued reports on $JPM in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- CICC issued a "Outperform" rating on 01/14/2026
- Barclays issued a "Overweight" rating on 01/05/2026
- Wells Fargo issued a "Overweight" rating on 11/03/2025
- UBS issued a "Buy" rating on 10/07/2025
- Evercore ISI Group issued a "Outperform" rating on 09/30/2025
To track analyst ratings and price targets for JPM, check out Quiver Quantitative's $JPM forecast page.
JPM Price Targets
Multiple analysts have issued price targets for $JPM recently. We have seen 9 analysts offer price targets for $JPM in the last 6 months, with a median target of $350.0.
Here are some recent targets:
- David Chiaverini from Jefferies set a target price of $310.0 on 03/26/2026
- Mike Mayo from Wells Fargo set a target price of $350.0 on 02/17/2026
- An analyst from CICC set a target price of $355.0 on 01/14/2026
- John McDonald from Truist Securities set a target price of $331.0 on 01/06/2026
- Jason Goldberg from Barclays set a target price of $391.0 on 01/05/2026
- David Konrad from Keefe, Bruyette & Woods set a target price of $363.0 on 12/17/2025
- Betsy Graseck from Morgan Stanley set a target price of $338.0 on 10/15/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$80,000 of FEDEX CORPORATION lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Changes in federal tax legislation; Proposals impacting corporate taxes; Monitoring of international trade issues; Executive orders impacting trade;"
You can find more data on corporate lobbying on Quiver Quantitative.
FDX Congressional Stock Trading
Members of Congress have traded $FDX stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $FDX stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 01/09.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
FDX Hedge Fund Activity
We have seen 824 institutional investors add shares of FDX stock to their portfolio, and 869 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 4,071,468 shares (-75.3%) from their portfolio in Q4 2025, for an estimated $1,176,084,246
- FMR LLC added 2,053,626 shares (+69.5%) to their portfolio in Q4 2025, for an estimated $593,210,406
- PRIMECAP MANAGEMENT CO/CA/ removed 929,579 shares (-9.8%) from their portfolio in Q4 2025, for an estimated $268,518,189
- BALYASNY ASSET MANAGEMENT L.P. added 745,703 shares (+27008.4%) to their portfolio in Q4 2025, for an estimated $215,403,768
- WADDELL & ASSOCIATES, LLC added 738,122 shares (+164.0%) to their portfolio in Q4 2025, for an estimated $213,213,920
- CAPITAL INTERNATIONAL INVESTORS removed 685,766 shares (-15.9%) from their portfolio in Q4 2025, for an estimated $198,090,366
- DODGE & COX removed 642,992 shares (-4.0%) from their portfolio in Q4 2025, for an estimated $185,734,669
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
FDX Analyst Ratings
Wall Street analysts have issued reports on $FDX in the last several months. We have seen 5 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Jefferies issued a "Buy" rating on 12/19/2025
- Stifel issued a "Buy" rating on 12/19/2025
- Stephens & Co. issued a "Overweight" rating on 12/19/2025
- Truist Securities issued a "Buy" rating on 12/19/2025
- Morgan Stanley issued a "Underweight" rating on 12/19/2025
- Citigroup issued a "Buy" rating on 12/19/2025
To track analyst ratings and price targets for FDX, check out Quiver Quantitative's $FDX forecast page.
FDX Price Targets
Multiple analysts have issued price targets for $FDX recently. We have seen 18 analysts offer price targets for $FDX in the last 6 months, with a median target of $417.5.
Here are some recent targets:
- Brian Ossenbeck from JP Morgan set a target price of $432.0 on 03/20/2026
- Reed Seay from Stephens & Co. set a target price of $435.0 on 03/20/2026
- Christian Wetherbee from Wells Fargo set a target price of $450.0 on 03/20/2026
- Lucas Servera from Truist Securities set a target price of $425.0 on 03/20/2026
- Bascome Majors from Susquehanna set a target price of $455.0 on 03/20/2026
- Fadi Chamoun from BMO Capital set a target price of $410.0 on 03/20/2026
- J. Bruce Chan from Stifel set a target price of $425.0 on 03/20/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$50,000 of SYSCO lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Education campaign with policymakers related to food distribution, supply chain, labor workforce, and food safety."
You can find more data on corporate lobbying on Quiver Quantitative.
SYY Congressional Stock Trading
Members of Congress have traded $SYY stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $SYY stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
SYY Insider Trading Activity
SYY insiders have traded $SYY stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $SYY stock by insiders over the last 6 months:
- RONALD L PHILLIPS (EVP and CHRO) sold 5,601 shares for an estimated $453,681
- SHEILA TALTON sold 2,801 shares for an estimated $232,454
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
SYY Hedge Fund Activity
We have seen 614 institutional investors add shares of SYY stock to their portfolio, and 846 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 14,933,214 shares (-76.0%) from their portfolio in Q4 2025, for an estimated $1,100,428,539
- AMERICAN CENTURY COMPANIES INC added 2,961,272 shares (+337.1%) to their portfolio in Q4 2025, for an estimated $218,216,133
- JPMORGAN CHASE & CO removed 2,478,724 shares (-62.5%) from their portfolio in Q4 2025, for an estimated $182,657,171
- BOSTON PARTNERS removed 1,763,222 shares (-14.1%) from their portfolio in Q4 2025, for an estimated $129,931,829
- MILLENNIUM MANAGEMENT LLC removed 1,545,778 shares (-47.7%) from their portfolio in Q4 2025, for an estimated $113,908,380
- QUBE RESEARCH & TECHNOLOGIES LTD added 1,442,942 shares (+inf%) to their portfolio in Q4 2025, for an estimated $106,330,395
- CANOE FINANCIAL LP removed 1,427,181 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $105,168,967
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
SYY Analyst Ratings
Wall Street analysts have issued reports on $SYY in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Jefferies issued a "Buy" rating on 01/28/2026
- JP Morgan issued a "Overweight" rating on 01/28/2026
- Wells Fargo issued a "Overweight" rating on 01/28/2026
- Barclays issued a "Overweight" rating on 01/28/2026
- Guggenheim issued a "Buy" rating on 10/06/2025
To track analyst ratings and price targets for SYY, check out Quiver Quantitative's $SYY forecast page.
SYY Price Targets
Multiple analysts have issued price targets for $SYY recently. We have seen 11 analysts offer price targets for $SYY in the last 6 months, with a median target of $92.0.
Here are some recent targets:
- Edward Kelly from Wells Fargo set a target price of $100.0 on 02/19/2026
- John Heinbockel from Guggenheim set a target price of $95.0 on 02/13/2026
- John Ivankoe from JP Morgan set a target price of $87.0 on 01/28/2026
- Jake Bartlett from Truist Securities set a target price of $94.0 on 01/28/2026
- Mark Carden from UBS set a target price of $95.0 on 01/28/2026
- Karen Holthouse from Citigroup set a target price of $88.0 on 01/28/2026
- Jeffrey Bernstein from Barclays set a target price of $92.0 on 01/28/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$24,000 of RAFAEL HOLDINGS INC. lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to rare pediatric disease Priority Review Vouchers; H.R. 1262/S. 932, Give Kids a Chance Act; S. 3302, Mikaela Naylon Give Kids a Chance Act of 2025."
You can find more data on corporate lobbying on Quiver Quantitative.
RFL Hedge Fund Activity
We have seen 11 institutional investors add shares of RFL stock to their portfolio, and 27 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CABLE CAR CAPITAL, LP removed 100,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $136,000
- KAHN BROTHERS GROUP INC removed 99,428 shares (-62.7%) from their portfolio in Q4 2025, for an estimated $117,325
- VANGUARD GROUP INC added 98,551 shares (+7.1%) to their portfolio in Q4 2025, for an estimated $116,290
- GEODE CAPITAL MANAGEMENT, LLC added 90,417 shares (+25.4%) to their portfolio in Q4 2025, for an estimated $106,692
- CITADEL ADVISORS LLC removed 31,181 shares (-43.0%) from their portfolio in Q4 2025, for an estimated $36,793
- PRICE T ROWE ASSOCIATES INC /MD/ removed 29,321 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $39,876
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 29,251 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $34,516
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$800,000 of COINBASE INC. lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"GENERAL DISCUSSIONS RELATED TO DIGITAL ASSET MARKET STRUCTURE H.R. 3633: DIGITAL ASSET MARKET CLARITY ACT OF 2025; ALL PROVISIONS S.1582: GENIUS ACT; ALL PROVISIONS GENERAL DISCUSSIONS RELATED TO GENERAL MARKET STRUCTURE H.R. 3633: DIGITAL ASSET MARKET CLARITY ACT OF 2025; ALL PROVISIONS S.1582: GENIUS ACT; ALL PROVISIONS GENERAL DISCUSSIONS RELATED TO GENERAL MARKET STRUCTURE GENERAL DISCUSSIONS RELATED TO DIGITAL ASSET TAX TREATMENT GENERAL DISCUSSIONS RELATED TO DIGITAL ASSET TAX"
You can find more data on corporate lobbying on Quiver Quantitative.
COIN Congressional Stock Trading
Members of Congress have traded $COIN stock 8 times in the past 6 months. Of those trades, 4 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $COIN stock by members of Congress over the last 6 months:
- REPRESENTATIVE TIM MOORE sold up to $15,000 on 02/18.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 7 times. They made 4 purchases worth up to $60,000 on 01/30, 11/18, 10/17, 10/09 and 3 sales worth up to $45,000 on 02/12, 12/24, 12/19.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
COIN Insider Trading Activity
COIN insiders have traded $COIN stock on the open market 195 times in the past 6 months. Of those trades, 0 have been purchases and 195 have been sales.
Here’s a breakdown of recent trading of $COIN stock by insiders over the last 6 months:
- FREDERICK ERNEST III EHRSAM has made 0 purchases and 33 sales selling 370,564 shares for an estimated $114,289,259.
- BRIAN ARMSTRONG (Chairman and CEO) has made 0 purchases and 47 sales selling 300,000 shares for an estimated $86,459,504.
- ALESIA J HAAS (CHIEF FINANCIAL OFFICER) has made 0 purchases and 19 sales selling 403,429 shares for an estimated $66,581,521.
- EMILIE CHOI (President & COO) has made 0 purchases and 13 sales selling 100,000 shares for an estimated $31,087,593.
- FREDERICK R WILSON has made 0 purchases and 41 sales selling 30,000 shares for an estimated $7,950,185.
- PAUL GREWAL (Chief Legal Officer) has made 0 purchases and 27 sales selling 24,245 shares for an estimated $6,885,624.
- LAWRENCE J BROCK (Chief People Officer) has made 0 purchases and 13 sales selling 5,902 shares for an estimated $1,478,896.
- JENNIFER N. JONES (Chief Accounting Officer) has made 0 purchases and 2 sales selling 2,656 shares for an estimated $662,782.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
COIN Hedge Fund Activity
We have seen 633 institutional investors add shares of COIN stock to their portfolio, and 767 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 3,163,191 shares (-74.2%) from their portfolio in Q4 2025, for an estimated $715,324,012
- FMR LLC removed 2,973,992 shares (-70.6%) from their portfolio in Q4 2025, for an estimated $672,538,550
- A16Z PERENNIAL MANAGEMENT, L.P. added 1,461,157 shares (+inf%) to their portfolio in Q4 2025, for an estimated $330,426,043
- CAPITAL WORLD INVESTORS added 1,374,318 shares (+847.2%) to their portfolio in Q4 2025, for an estimated $310,788,272
- INVESCO LTD. added 1,080,707 shares (+74.3%) to their portfolio in Q4 2025, for an estimated $244,391,080
- BLACKROCK, INC. added 965,033 shares (+6.0%) to their portfolio in Q4 2025, for an estimated $218,232,562
- NATIONAL BANK OF CANADA /FI/ removed 939,669 shares (-94.4%) from their portfolio in Q4 2025, for an estimated $212,496,747
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
COIN Analyst Ratings
Wall Street analysts have issued reports on $COIN in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Needham issued a "Buy" rating on 02/13/2026
- BTIG issued a "Buy" rating on 02/13/2026
- B of A Securities issued a "Buy" rating on 01/08/2026
- Deutsche Bank issued a "Buy" rating on 12/17/2025
- Monness, Crespi, Hardt issued a "Buy" rating on 11/10/2025
- HC Wainwright & Co. issued a "Buy" rating on 10/31/2025
- JP Morgan issued a "Overweight" rating on 10/31/2025
To track analyst ratings and price targets for COIN, check out Quiver Quantitative's $COIN forecast page.
COIN Price Targets
Multiple analysts have issued price targets for $COIN recently. We have seen 21 analysts offer price targets for $COIN in the last 6 months, with a median target of $280.0.
Here are some recent targets:
- Robert Oliver from Baird set a target price of $215.0 on 03/17/2026
- Dan Dolev from Mizuho set a target price of $170.0 on 02/17/2026
- James Yaro from Goldman Sachs set a target price of $264.0 on 02/17/2026
- Joseph Vafi from Canaccord Genuity set a target price of $300.0 on 02/13/2026
- John Todaro from Needham set a target price of $230.0 on 02/13/2026
- Mark Palmer from Benchmark set a target price of $267.0 on 02/13/2026
- Patrick Moley from Piper Sandler set a target price of $150.0 on 02/13/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$198,000 of WESTERN UNION lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Cross border remittance issues; remittance issues related to Cuba; legal issues related to the Democratic Republic of Congo; issues related to Ukrainian sanctions; remittance activity and outbound remittance activity from Iraq; bank de-risking; general issues concerning money service businesses; anti-money laundering and terrorist finance issues including money service business know your customer and know your agent requirements; issues related to the implementation of the Dodd-Frank Act regarding remittances; issues related to financial fraud; privacy and related issues working with law enforcement; human trafficking; identification requirements for consumers utilizing money transmitters; taxes and/ or fees related to money transmission/ remittances and the budget reconciliation process. Cross border remittance issues; remittance issues related to Cuba; legal issues related to the Democratic Republic of Congo; issues related to Ukrainian sanctions; remittance activity and outbound remittance activity from Iraq; bank de-risking; general issues concerning money service businesses; anti-money laundering and terrorist finance issues including money service business know your customer and know your agent requirements; issues related to the implementation of the Dodd-Frank Act regarding remittances; issues related to financial fraud; privacy and related issues working with law enforcement; human trafficking; identification requirements for consumers utilizing money transmitters; taxes and/ or fees related to money transmission/ remittances and the budget reconciliation process. General remittance issues; human trafficking and smuggling issues; taxes and/ or fees related to money transmission/ remittances and the budget reconciliation process. General remittance issues; human trafficking and smuggling issues; taxes and/ or fees related to money transmission/ remittances and the budget reconciliation process. Remittance Tax and Reconciliation legislation Cuba remittances, remittances generally to various countries, remittances to Somalia Remittance taxes and the reconciliation process, Remittance tax and implementation thereof, remittance tax and the reconciliation process, section 163(j) deduction of foreign interest/expenses"
You can find more data on corporate lobbying on Quiver Quantitative.
WU Insider Trading Activity
WU insiders have traded $WU stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $WU stock by insiders over the last 6 months:
- GIOVANNI ANGELINI (President Europe, Africa, MEPA) purchased 10,000 shares for an estimated $89,540
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
WU Hedge Fund Activity
We have seen 247 institutional investors add shares of WU stock to their portfolio, and 287 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ROYAL BANK OF CANADA removed 10,644,796 shares (-87.7%) from their portfolio in Q4 2025, for an estimated $99,103,050
- SG AMERICAS SECURITIES, LLC added 7,886,978 shares (+11759.8%) to their portfolio in Q4 2025, for an estimated $73,427,765
- GOLDMAN SACHS GROUP INC added 6,087,613 shares (+401.4%) to their portfolio in Q4 2025, for an estimated $56,675,677
- TWO SIGMA INVESTMENTS, LP added 4,966,422 shares (+1018.4%) to their portfolio in Q4 2025, for an estimated $46,237,388
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 3,996,755 shares (-76.3%) from their portfolio in Q4 2025, for an estimated $37,209,789
- J. GOLDMAN & CO LP added 3,970,718 shares (+inf%) to their portfolio in Q4 2025, for an estimated $36,967,384
- MARSHALL WACE, LLP added 3,633,049 shares (+3370.2%) to their portfolio in Q4 2025, for an estimated $33,823,686
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
WU Price Targets
Multiple analysts have issued price targets for $WU recently. We have seen 5 analysts offer price targets for $WU in the last 6 months, with a median target of $9.0.
Here are some recent targets:
- Ramsey El-Assal from Cantor Fitzgerald set a target price of $9.0 on 01/27/2026
- Sanjay Sakhrani from Keefe, Bruyette & Woods set a target price of $10.0 on 01/02/2026
- James Friedman from Susquehanna set a target price of $10.0 on 11/10/2025
- Timothy Chiodo from UBS set a target price of $9.0 on 11/10/2025
- Bryan Keane from Citigroup set a target price of $9.0 on 10/22/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$100,000 of MODERNA INC. lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Vaccine Policy"
You can find more data on corporate lobbying on Quiver Quantitative.
MRNA Insider Trading Activity
MRNA insiders have traded $MRNA stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $MRNA stock by insiders over the last 6 months:
- STEPHEN HOGE (President) sold 160,009 shares for an estimated $7,814,839
- SHANNON THYME KLINGER (Chief Legal Officer) sold 13,885 shares for an estimated $726,046
- NOUBAR AFEYAN sold 23,853 shares for an estimated $703,305
- ABBAS HUSSAIN sold 504 shares for an estimated $13,910
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
MRNA Hedge Fund Activity
We have seen 258 institutional investors add shares of MRNA stock to their portfolio, and 397 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 15,741,014 shares (+127.9%) to their portfolio in Q4 2025, for an estimated $464,202,502
- CAPITAL WORLD INVESTORS added 12,828,040 shares (+inf%) to their portfolio in Q4 2025, for an estimated $378,298,899
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 6,254,709 shares (-79.7%) from their portfolio in Q4 2025, for an estimated $184,451,368
- ALYESKA INVESTMENT GROUP, L.P. added 3,228,531 shares (+inf%) to their portfolio in Q4 2025, for an estimated $95,209,379
- BNP PARIBAS FINANCIAL MARKETS added 3,058,933 shares (+279.7%) to their portfolio in Q4 2025, for an estimated $90,207,934
- BLACKROCK, INC. added 2,977,816 shares (+10.1%) to their portfolio in Q4 2025, for an estimated $87,815,793
- CITADEL ADVISORS LLC removed 1,408,601 shares (-70.9%) from their portfolio in Q4 2025, for an estimated $41,539,643
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
MRNA Analyst Ratings
Wall Street analysts have issued reports on $MRNA in the last several months. We have seen 2 firms issue buy ratings on the stock, and 3 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 02/23/2026
- Leerink Partners issued a "Underperform" rating on 11/21/2025
- B of A Securities issued a "Underperform" rating on 11/10/2025
- UBS issued a "Buy" rating on 10/23/2025
- JP Morgan issued a "Underweight" rating on 10/23/2025
To track analyst ratings and price targets for MRNA, check out Quiver Quantitative's $MRNA forecast page.
MRNA Price Targets
Multiple analysts have issued price targets for $MRNA recently. We have seen 12 analysts offer price targets for $MRNA in the last 6 months, with a median target of $29.0.
Here are some recent targets:
- Edward Tenthoff from Piper Sandler set a target price of $69.0 on 02/23/2026
- Cory Kasimov from Evercore ISI Group set a target price of $35.0 on 02/17/2026
- Salveen Richter from Goldman Sachs set a target price of $41.0 on 02/17/2026
- Luca Issi from RBC Capital set a target price of $30.0 on 02/17/2026
- Eliana Merle from UBS set a target price of $34.0 on 01/07/2026
- Andrew Tsai from Jefferies set a target price of $30.0 on 12/12/2025
- Matthew Harrison from Morgan Stanley set a target price of $28.0 on 12/12/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$80,000 of MCCORMICK & COMPANY INCORPORATED lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to tariffs Issues related to upcoming tax debate"
You can find more data on corporate lobbying on Quiver Quantitative.
MKC Congressional Stock Trading
Members of Congress have traded $MKC stock 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $MKC stock by members of Congress over the last 6 months:
- REPRESENTATIVE JULIA LETLOW sold up to $15,000 on 02/02.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 09/25.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
MKC Insider Trading Activity
MKC insiders have traded $MKC stock on the open market 12 times in the past 6 months. Of those trades, 0 have been purchases and 12 have been sales.
Here’s a breakdown of recent trading of $MKC stock by insiders over the last 6 months:
- LAWRENCE ERIK KURZIUS has made 0 purchases and 8 sales selling 189,014 shares for an estimated $12,763,963.
- BRENDAN M FOLEY (Chairman, President & CEO) sold 57,144 shares for an estimated $3,746,360
- JACQUES TAPIERO has made 0 purchases and 2 sales selling 10,000 shares for an estimated $654,700.
- MICHAEL D MANGAN sold 5,000 shares for an estimated $339,600
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
MKC Hedge Fund Activity
We have seen 376 institutional investors add shares of MKC stock to their portfolio, and 645 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 9,203,927 shares (-74.5%) from their portfolio in Q4 2025, for an estimated $626,879,467
- ARISTOTLE CAPITAL MANAGEMENT, LLC added 3,816,143 shares (+inf%) to their portfolio in Q4 2025, for an estimated $259,917,499
- ILEX CAPITAL PARTNERS (UK) LLP added 3,201,107 shares (+inf%) to their portfolio in Q4 2025, for an estimated $218,027,397
- FMR LLC added 2,969,374 shares (+163.4%) to their portfolio in Q4 2025, for an estimated $202,244,063
- NORGES BANK removed 2,364,511 shares (-72.0%) from their portfolio in Q4 2025, for an estimated $161,046,844
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 2,092,281 shares (-34.5%) from their portfolio in Q4 2025, for an estimated $142,505,258
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 1,742,596 shares (-69.7%) from their portfolio in Q4 2025, for an estimated $118,688,213
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
MKC Analyst Ratings
Wall Street analysts have issued reports on $MKC in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Overweight" rating on 09/25/2025
To track analyst ratings and price targets for MKC, check out Quiver Quantitative's $MKC forecast page.
MKC Price Targets
Multiple analysts have issued price targets for $MKC recently. We have seen 8 analysts offer price targets for $MKC in the last 6 months, with a median target of $69.0.
Here are some recent targets:
- Peter Grom from UBS set a target price of $59.0 on 03/20/2026
- Andrew Lazar from Barclays set a target price of $67.0 on 01/26/2026
- Matthew Smith from Stifel set a target price of $65.0 on 01/23/2026
- Alexia Howard from Bernstein set a target price of $93.0 on 10/08/2025
- Stephen Powers from Deutsche Bank set a target price of $71.0 on 10/08/2025
- Rob Dickerson from Jefferies set a target price of $78.0 on 10/08/2025
- Thomas Palmer from JP Morgan set a target price of $82.0 on 09/25/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$20,000 of DARLING INGREDIENTS INC lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Support for higher renewal volume obligations under the Renewable Fuel Standard Support for the renewable diesel/biodiesel tax incentives, SAF tax incentives, and the Clean Fuel Production Credit (Section 45Z) Support for the CFPC (Section 45Z), including the restoration of the SAF differential"
You can find more data on corporate lobbying on Quiver Quantitative.
DAR Insider Trading Activity
DAR insiders have traded $DAR stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $DAR stock by insiders over the last 6 months:
- DER VELDEN JAN VAN (EVP Int Rendering&Specialties) has made 0 purchases and 2 sales selling 23,000 shares for an estimated $1,178,270.
- SANDRA DUDLEY (EVP Chief Strategy Officer) has made 0 purchases and 3 sales selling 8,651 shares for an estimated $447,983.
- NICHOLAS JAMES KEMPHAUS (EVP Gen. Counsel & Secretary) has made 0 purchases and 4 sales selling 5,830 shares for an estimated $303,955.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
DAR Hedge Fund Activity
We have seen 213 institutional investors add shares of DAR stock to their portfolio, and 304 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILLENNIUM MANAGEMENT LLC added 5,070,434 shares (+458.9%) to their portfolio in Q4 2025, for an estimated $182,535,624
- UBS GROUP AG removed 4,082,495 shares (-44.5%) from their portfolio in Q4 2025, for an estimated $146,969,820
- ILEX CAPITAL PARTNERS (UK) LLP removed 3,251,180 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $117,042,480
- BARROW HANLEY MEWHINNEY & STRAUSS LLC removed 2,713,763 shares (-53.0%) from their portfolio in Q4 2025, for an estimated $97,695,468
- CITADEL ADVISORS LLC removed 2,603,033 shares (-52.6%) from their portfolio in Q4 2025, for an estimated $93,709,188
- APPIAN WAY ASSET MANAGEMENT LP added 1,679,064 shares (+2551.8%) to their portfolio in Q3 2025, for an estimated $51,832,705
- POINT72 ASSET MANAGEMENT, L.P. added 1,412,983 shares (+333.3%) to their portfolio in Q4 2025, for an estimated $50,867,388
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
DAR Analyst Ratings
Wall Street analysts have issued reports on $DAR in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Jefferies issued a "Buy" rating on 10/24/2025
- Piper Sandler issued a "Overweight" rating on 10/24/2025
- B of A Securities issued a "Buy" rating on 10/08/2025
To track analyst ratings and price targets for DAR, check out Quiver Quantitative's $DAR forecast page.
DAR Price Targets
Multiple analysts have issued price targets for $DAR recently. We have seen 7 analysts offer price targets for $DAR in the last 6 months, with a median target of $50.0.
Here are some recent targets:
- Andrew Strelzik from BMO Capital set a target price of $57.0 on 02/13/2026
- Jason Gabelman from TD Cowen set a target price of $58.0 on 02/13/2026
- Ryan Todd from Piper Sandler set a target price of $65.0 on 02/13/2026
- Thomas Palmer from JP Morgan set a target price of $46.0 on 01/21/2026
- Dushyant Ailani from Jefferies set a target price of $50.0 on 01/12/2026
- Conor Fitzpatrick from B of A Securities set a target price of $45.0 on 10/08/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$1,550,000 of UNITED AIRLINES INC lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Customer-related issues. Air Traffic Control Reform, Staffing, and Modernization. Government Shutdown Impacts on Federal Aviation Administration. DOT and FAA Regulations. S. 1045/H.R. 5455, Aviation Funding Stability Act, to provide funding for the FAA in the event of a lapse in appropriations. H.R. 6086, Aviation Funding Solvency Act, to provide funding for the FAA in the event of a lapse in appropriations. S. 697, Air Traffic Control Workforce Development Act of 2025, all provisions. S. 1985, Safe Operations of Shared Airspace Act of 2025, most provisions. H.R. 3530, Flight Education Access Act, all provisions. H.R. 2591/S. 3257, Mental Health in Aviation Act of 2025, all provisions. H.R. 2592, Aviation Medication Transparency Act of 2025, all provisions. P.L. 118-63, FAA Reauthorization Act of 2024, most provisions. Credit Card Competition Act (no current bill number). H.R. 1719/S. 144, Farm to Fly Act of 2025, all provisions. S. 1422, Fanner First Fuel Incentives Act, provisions related to aviation. S. 2503, ROTOR Act, all provisions. H.R. 6518, SAF Act, all provisions. Issues pertaining to security screening and biometric technology. Issues pertaining to cabotage regulations. Issues pertaining to airline frequent flyer programs. Issues pertaining to airline workforce and labor. Issues pertaining to FCC spectrum auction/aircraft radio altimeter interference. Issues pertaining to Department of State Travel Advisory Requirements. Budget Reconciliation - Air Traffic Controller Staffing. Budget and appropriations related to the airline industry for Fiscal Year 2025 and Fiscal Year 2026. Issues pertaining to Aviation taxes and fees. Issues pertaining to Sustainable Aviation Fuels. Issues pertaining to Sustainable Aviation Fuels."
You can find more data on corporate lobbying on Quiver Quantitative.
UAL Congressional Stock Trading
Members of Congress have traded $UAL stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $UAL stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $15,000 on 12/19 and 1 sale worth up to $15,000 on 02/10.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
UAL Insider Trading Activity
UAL insiders have traded $UAL stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $UAL stock by insiders over the last 6 months:
- J SCOTT KIRBY (Chief Executive Officer) sold 120,000 shares for an estimated $12,943,800
- BRETT J HART (President) sold 19,000 shares for an estimated $2,022,568
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
UAL Hedge Fund Activity
We have seen 546 institutional investors add shares of UAL stock to their portfolio, and 458 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL INTERNATIONAL INVESTORS removed 3,815,497 shares (-17.3%) from their portfolio in Q4 2025, for an estimated $426,648,874
- BALYASNY ASSET MANAGEMENT L.P. removed 2,641,208 shares (-99.8%) from their portfolio in Q4 2025, for an estimated $295,339,878
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 2,048,224 shares (-72.5%) from their portfolio in Q4 2025, for an estimated $229,032,407
- PRIMECAP MANAGEMENT CO/CA/ removed 2,024,470 shares (-11.2%) from their portfolio in Q4 2025, for an estimated $226,376,235
- FMR LLC added 1,857,987 shares (+12.8%) to their portfolio in Q4 2025, for an estimated $207,760,106
- HOLOCENE ADVISORS, LP removed 1,491,352 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $166,762,980
- TWO SIGMA INVESTMENTS, LP added 1,305,748 shares (+3647.3%) to their portfolio in Q4 2025, for an estimated $146,008,741
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
UAL Analyst Ratings
Wall Street analysts have issued reports on $UAL in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- TD Cowen issued a "Buy" rating on 01/22/2026
- Barclays issued a "Overweight" rating on 01/12/2026
- UBS issued a "Buy" rating on 01/06/2026
- Wells Fargo issued a "Overweight" rating on 12/18/2025
- BMO Capital issued a "Outperform" rating on 12/09/2025
- Susquehanna issued a "Positive" rating on 10/03/2025
- Jefferies issued a "Buy" rating on 10/01/2025
To track analyst ratings and price targets for UAL, check out Quiver Quantitative's $UAL forecast page.
UAL Price Targets
Multiple analysts have issued price targets for $UAL recently. We have seen 15 analysts offer price targets for $UAL in the last 6 months, with a median target of $130.0.
Here are some recent targets:
- Sheila Kahyaoglu from Jefferies set a target price of $125.0 on 03/12/2026
- Duane Pfennigwerth from Evercore ISI Group set a target price of $125.0 on 03/12/2026
- Tom Fitzgerald from TD Cowen set a target price of $128.0 on 03/09/2026
- James Goodall from Rothschild & Co set a target price of $110.0 on 03/05/2026
- Atul Maheswari from UBS set a target price of $147.0 on 01/22/2026
- John Staszak from Argus Research set a target price of $135.0 on 01/22/2026
- Catherine O'Brien from Goldman Sachs set a target price of $129.0 on 01/13/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$250,000 of BRIGHTSPRING HEALTH SERVICES lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Long-term care pharmacy and other pharmacy issues HR 5130/S 3159, IRA implementation issues included), Medicare payment rules including hospice, home health and physician fee schedule (HR 5142 included), home infusion fix, Medicaid regulations, workforce development Long-term care pharmacy fix, IRA implementation"
You can find more data on corporate lobbying on Quiver Quantitative.
BTSG Insider Trading Activity
BTSG insiders have traded $BTSG stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $BTSG stock by insiders over the last 6 months:
- GROUP PARTNERSHIP L.P. KKR has made 0 purchases and 2 sales selling 34,460,000 shares for an estimated $1,231,936,705.
- PHOENIX AGGREGATOR L.P. KKR has made 0 purchases and 2 sales selling 34,460,000 shares for an estimated $1,231,936,705.
- JON B ROUSSEAU (See Remarks) has made 0 purchases and 2 sales selling 455,000 shares for an estimated $15,816,770.
- LISA A NALLEY (See Remarks) has made 0 purchases and 2 sales selling 50,000 shares for an estimated $1,810,140.
- JENNIFER A PHIPPS (Chief Financial Officer) sold 35,000 shares for an estimated $1,440,250
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
BTSG Hedge Fund Activity
We have seen 192 institutional investors add shares of BTSG stock to their portfolio, and 128 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- KOHLBERG KRAVIS ROBERTS & CO. L.P. removed 15,154,305 shares (-19.7%) from their portfolio in Q4 2025, for an estimated $567,528,722
- BLACKROCK, INC. added 9,372,929 shares (+123.1%) to their portfolio in Q4 2025, for an estimated $351,016,191
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 3,958,691 shares (-78.7%) from their portfolio in Q4 2025, for an estimated $148,252,977
- VANGUARD GROUP INC added 2,928,953 shares (+30.5%) to their portfolio in Q4 2025, for an estimated $109,689,289
- FMR LLC removed 2,325,097 shares (-9.3%) from their portfolio in Q4 2025, for an estimated $87,074,882
- ROYAL BANK OF CANADA removed 2,198,147 shares (-99.6%) from their portfolio in Q4 2025, for an estimated $82,320,605
- STATE STREET CORP added 2,011,095 shares (+99.5%) to their portfolio in Q4 2025, for an estimated $75,315,507
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
BTSG Analyst Ratings
Wall Street analysts have issued reports on $BTSG in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 01/07/2026
- BTIG issued a "Buy" rating on 12/23/2025
- Stephens & Co. issued a "Overweight" rating on 12/11/2025
- William Blair issued a "Outperform" rating on 12/08/2025
- BMO Capital issued a "Outperform" rating on 11/13/2025
- Mizuho issued a "Outperform" rating on 10/17/2025
- Morgan Stanley issued a "Overweight" rating on 10/14/2025
To track analyst ratings and price targets for BTSG, check out Quiver Quantitative's $BTSG forecast page.
BTSG Price Targets
Multiple analysts have issued price targets for $BTSG recently. We have seen 9 analysts offer price targets for $BTSG in the last 6 months, with a median target of $45.0.
Here are some recent targets:
- Erin Wright from Morgan Stanley set a target price of $48.0 on 03/04/2026
- Ann Hynes from Mizuho set a target price of $50.0 on 03/03/2026
- Stephen Baxter from Wells Fargo set a target price of $50.0 on 03/02/2026
- David Larsen from BTIG set a target price of $55.0 on 03/02/2026
- Matthew Gillmor from Keybanc set a target price of $45.0 on 12/12/2025
- Dean Sublett from Stephens & Co. set a target price of $44.0 on 12/11/2025
- Joanna Gajuk from B of A Securities set a target price of $41.0 on 12/09/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$480,000 of CAPITAL ONE FINANCIAL CORPORATION lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"H.R.1 - One Big Beautiful Bill Act; General issues impacting the tax code, including corporate tax rate and tax credit supported programs. Issues related to antitrust General issues impacting consumer and commercial loans including payment systems, emerging payments, loan terms and product features, and the regulation of banking"
You can find more data on corporate lobbying on Quiver Quantitative.
COF Congressional Stock Trading
Members of Congress have traded $COF stock 7 times in the past 6 months. Of those trades, 3 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $COF stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $15,000 on 01/09 and 1 sale worth up to $15,000 on 02/10.
- SENATOR MARKWAYNE MULLIN has traded it 2 times. They made 2 purchases worth up to $200,000 on 12/29, 11/10 and 0 sales.
- REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/18, 11/13.
- REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
COF Insider Trading Activity
COF insiders have traded $COF stock on the open market 43 times in the past 6 months. Of those trades, 0 have been purchases and 43 have been sales.
Here’s a breakdown of recent trading of $COF stock by insiders over the last 6 months:
- RICHARD D FAIRBANK (Chairman and CEO) has made 0 purchases and 17 sales selling 206,973 shares for an estimated $46,192,770.
- NEAL BLINDE (President, Commercial Banking) has made 0 purchases and 9 sales selling 81,335 shares for an estimated $16,848,294.
- FRANK G. LAPRADE,III (Chief Enterprise Srvcs Officer) has made 0 purchases and 2 sales selling 17,840 shares for an estimated $3,961,081.
- RAVI RAGHU (Pres, Software, Intl & Sm Bus) sold 13,450 shares for an estimated $3,362,500
- LIA DEAN (Pres, Banking & Prem. Products) has made 0 purchases and 3 sales selling 9,716 shares for an estimated $2,220,576.
- MATTHEW W COOPER (General Counsel & Corp Secy) has made 0 purchases and 4 sales selling 8,000 shares for an estimated $1,805,880.
- CELIA KARAM (Pres, Retail Bank) has made 0 purchases and 3 sales selling 7,108 shares for an estimated $1,604,897.
- JASON P. HANSON (Pres.- Global Payment Network) sold 3,729 shares for an estimated $764,445
- MARK DANIEL MOUADEB (President, Card) has made 0 purchases and 3 sales selling 3,102 shares for an estimated $640,285.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
COF Hedge Fund Activity
We have seen 1,059 institutional investors add shares of COF stock to their portfolio, and 922 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 20,657,617 shares (-75.2%) from their portfolio in Q4 2025, for an estimated $5,006,580,056
- VIKING GLOBAL INVESTORS LP removed 4,436,189 shares (-60.0%) from their portfolio in Q4 2025, for an estimated $1,075,154,766
- DODGE & COX removed 2,944,850 shares (-24.3%) from their portfolio in Q4 2025, for an estimated $713,713,846
- CAPITAL RESEARCH GLOBAL INVESTORS removed 2,538,515 shares (-30.1%) from their portfolio in Q4 2025, for an estimated $615,234,495
- FMR LLC added 2,026,496 shares (+12.1%) to their portfolio in Q4 2025, for an estimated $491,141,570
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 1,887,957 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $401,341,899
- HARRIS ASSOCIATES L P added 1,800,024 shares (+19.9%) to their portfolio in Q4 2025, for an estimated $436,253,816
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
COF Analyst Ratings
Wall Street analysts have issued reports on $COF in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 01/23/2026
- Morgan Stanley issued a "Overweight" rating on 01/20/2026
- TD Cowen issued a "Buy" rating on 01/08/2026
- Barclays issued a "Overweight" rating on 01/06/2026
- Citigroup issued a "Buy" rating on 12/31/2025
- UBS issued a "Buy" rating on 10/07/2025
- Evercore ISI Group issued a "Outperform" rating on 09/30/2025
To track analyst ratings and price targets for COF, check out Quiver Quantitative's $COF forecast page.
COF Price Targets
Multiple analysts have issued price targets for $COF recently. We have seen 13 analysts offer price targets for $COF in the last 6 months, with a median target of $275.0.
Here are some recent targets:
- Brian Foran from Truist Securities set a target price of $275.0 on 01/27/2026
- Terry Ma from Barclays set a target price of $287.0 on 01/26/2026
- Vincent Caintic from BTIG set a target price of $270.0 on 01/23/2026
- Jeffrey Adelson from Morgan Stanley set a target price of $300.0 on 01/20/2026
- Richard Shane from JP Morgan set a target price of $256.0 on 01/12/2026
- Moshe Orenbuch from TD Cowen set a target price of $290.0 on 01/08/2026
- Donald Fandetti from Wells Fargo set a target price of $280.0 on 01/05/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$60,000 of HONEYWELL INTERNATIONAL lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"General outreach"
You can find more data on corporate lobbying on Quiver Quantitative.
HON Congressional Stock Trading
Members of Congress have traded $HON stock 4 times in the past 6 months. Of those trades, 2 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $HON stock by members of Congress over the last 6 months:
- SENATOR ANGUS S. KING JR. purchased up to $15,000 on 12/29.
- REPRESENTATIVE DEBBIE DINGELL sold up to $50,000 on 11/24.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 11/18.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 09/25.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
HON Insider Trading Activity
HON insiders have traded $HON stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $HON stock by insiders over the last 6 months:
- GRACE LIEBLEIN has made 0 purchases and 3 sales selling 5,847 shares for an estimated $1,425,089.
- ROBERT D. MAILLOUX (Vice President & Controller) sold 5,274 shares for an estimated $1,260,486
- D SCOTT DAVIS sold 2,367 shares for an estimated $568,080
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
HON Hedge Fund Activity
We have seen 1,112 institutional investors add shares of HON stock to their portfolio, and 1,428 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- J. STERN & CO. LLP added 52,975,716 shares (+22704.6%) to their portfolio in Q4 2025, for an estimated $10,335,032,434
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 9,237,983 shares (-71.4%) from their portfolio in Q4 2025, for an estimated $1,802,238,103
- SG AMERICAS SECURITIES, LLC added 4,046,879 shares (+36520.9%) to their portfolio in Q4 2025, for an estimated $789,505,624
- BLACKROCK, INC. added 3,582,757 shares (+7.3%) to their portfolio in Q4 2025, for an estimated $698,960,063
- BARCLAYS PLC removed 3,189,870 shares (-34.8%) from their portfolio in Q4 2025, for an estimated $622,311,738
- NOMURA HOLDINGS INC removed 3,141,472 shares (-80.0%) from their portfolio in Q4 2025, for an estimated $612,869,772
- JPMORGAN CHASE & CO removed 2,457,297 shares (-23.8%) from their portfolio in Q4 2025, for an estimated $479,394,071
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
HON Analyst Ratings
Wall Street analysts have issued reports on $HON in the last several months. We have seen 5 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 01/30/2026
- JP Morgan issued a "Overweight" rating on 01/30/2026
- Citigroup issued a "Buy" rating on 01/12/2026
- B of A Securities issued a "Underperform" rating on 11/18/2025
- TD Cowen issued a "Buy" rating on 11/10/2025
- RBC Capital issued a "Outperform" rating on 10/27/2025
To track analyst ratings and price targets for HON, check out Quiver Quantitative's $HON forecast page.
HON Price Targets
Multiple analysts have issued price targets for $HON recently. We have seen 12 analysts offer price targets for $HON in the last 6 months, with a median target of $250.0.
Here are some recent targets:
- Chris Snyder from Morgan Stanley set a target price of $245.0 on 03/12/2026
- Sheila Kahyaoglu from Jefferies set a target price of $245.0 on 03/04/2026
- Julian Mitchell from Barclays set a target price of $275.0 on 03/04/2026
- Nigel Coe from Wolfe Research set a target price of $293.0 on 02/27/2026
- Andrew Kaplowitz from Citigroup set a target price of $265.0 on 01/30/2026
- Deane Dray from RBC Capital set a target price of $268.0 on 01/30/2026
- Stephen Tusa from JP Morgan set a target price of $260.0 on 01/30/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$2,870,000 of PFIZER INC. lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Vaccine Policy, Coverage and Access HR 4317 - PMB Reform Act of 2025 Gavi Vaccines Alliance Issues HR 2214 - DRUG Act S 832 - EPIC Act of 2025 S 864 - HELP Copays ACT S 882 - Patients Before Middlemen Act Prescription Drug-Use-Related Software (PDURS): Digital Medicine Lyme Disease Issues Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients IRA Biosimilars Pause Fix, Biosimilar Legislation H.R. 5256 - 340B Access ACT Inflation Reduction Act (IRA): Orphan Drug Exemption, Pill Penalty, Biosimilar Pause Vaccine Coverage and Access Drug Pricing Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients PBM Reform S 1702 - Access to Prescription Digital Therapeutics Act of 2025 Digital Therapeutics International Supply Chain Global Access Most Favored Nation Policies Tariffs Non-Tariff Trade Barriers United States-Mexico-Canada Agreement (USMCA)"
You can find more data on corporate lobbying on Quiver Quantitative.
PFE Congressional Stock Trading
Members of Congress have traded $PFE stock 4 times in the past 6 months. Of those trades, 2 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $PFE stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 2 purchases worth up to $30,000 on 02/10, 11/18 and 1 sale worth up to $15,000 on 12/19.
- REPRESENTATIVE J. FRENCH HILL sold up to $250,000 on 12/31.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
PFE Hedge Fund Activity
We have seen 1,255 institutional investors add shares of PFE stock to their portfolio, and 1,588 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 101,068,901 shares (-73.9%) from their portfolio in Q4 2025, for an estimated $2,516,615,634
- NORGES BANK removed 20,119,761 shares (-21.5%) from their portfolio in Q4 2025, for an estimated $500,982,048
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 17,862,459 shares (-96.2%) from their portfolio in Q4 2025, for an estimated $444,775,229
- PACER ADVISORS, INC. removed 17,574,851 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $437,613,789
- MORGAN STANLEY added 14,342,946 shares (+19.2%) to their portfolio in Q4 2025, for an estimated $357,139,355
- BANK OF NEW YORK MELLON CORP added 13,581,757 shares (+38.9%) to their portfolio in Q4 2025, for an estimated $338,185,749
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 8,837,922 shares (-70.2%) from their portfolio in Q4 2025, for an estimated $220,064,257
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
PFE Analyst Ratings
Wall Street analysts have issued reports on $PFE in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Guggenheim issued a "Buy" rating on 11/24/2025
To track analyst ratings and price targets for PFE, check out Quiver Quantitative's $PFE forecast page.
PFE Price Targets
Multiple analysts have issued price targets for $PFE recently. We have seen 10 analysts offer price targets for $PFE in the last 6 months, with a median target of $27.0.
Here are some recent targets:
- David Toung from Argus Research set a target price of $35.0 on 03/02/2026
- Trung Huynh from RBC Capital set a target price of $25.0 on 02/25/2026
- Emily Field from Barclays set a target price of $25.0 on 02/20/2026
- Carter Gould from Cantor Fitzgerald set a target price of $27.0 on 02/04/2026
- Michael Yee from UBS set a target price of $25.0 on 01/07/2026
- Terence Flynn from Morgan Stanley set a target price of $27.0 on 12/17/2025
- Jason Gerberry from B of A Securities set a target price of $28.0 on 12/15/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$80,000 of COHERUS BIOSCIENCES INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to oncology, Medicare coverage, domestic production of essential drugs, supply chain security, PILLS Act, Biosecure Act, Loans and grants for biologic production Issues related to drug development, oncology, IRA implementation, supply chain security, BIOSECURE as a policy matter, PILLS Act, and domestic production of essential drugs. Strategic National Stockpile of acute radiation syndrome medical counter measures. Administration for Strategic Preparedness & Response."
You can find more data on corporate lobbying on Quiver Quantitative.
CHRS Hedge Fund Activity
We have seen 60 institutional investors add shares of CHRS stock to their portfolio, and 59 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TANG CAPITAL MANAGEMENT LLC removed 2,372,853 shares (-46.6%) from their portfolio in Q4 2025, for an estimated $3,369,451
- MACQUARIE GROUP LTD removed 899,999 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $1,277,998
- RUBRIC CAPITAL MANAGEMENT LP removed 867,800 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $1,423,192
- TEJARA CAPITAL LTD removed 698,770 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $1,145,982
- MILLENNIUM MANAGEMENT LLC added 660,451 shares (+inf%) to their portfolio in Q4 2025, for an estimated $937,840
- GSA CAPITAL PARTNERS LLP added 477,481 shares (+inf%) to their portfolio in Q4 2025, for an estimated $678,023
- TWO SIGMA INVESTMENTS, LP added 468,163 shares (+1310.9%) to their portfolio in Q4 2025, for an estimated $664,791
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$50,000 of NIOCORP DEVELOPMENTS LTD lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"General issues related to critical minerals mining, processing, and security. Critical Minerals Investment Tax Modernization Act (H.R.4772). National Defense Authorization Act for Fiscal Year 2026 (P.L. 119-60). FY2026 Defense Appropriations legislation Critical Minerals Investment Tax Modernization Act (H.R.4772)."
You can find more data on corporate lobbying on Quiver Quantitative.
NB Hedge Fund Activity
We have seen 137 institutional investors add shares of NB stock to their portfolio, and 54 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CITADEL ADVISORS LLC removed 7,715,744 shares (-97.5%) from their portfolio in Q4 2025, for an estimated $40,893,443
- BLACKROCK, INC. added 2,729,334 shares (+74.7%) to their portfolio in Q4 2025, for an estimated $14,465,470
- ALYESKA INVESTMENT GROUP, L.P. removed 1,201,102 shares (-42.9%) from their portfolio in Q4 2025, for an estimated $6,365,840
- MARSHALL WACE, LLP removed 1,156,057 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $6,127,102
- BREVAN HOWARD CAPITAL MANAGEMENT LP added 1,109,874 shares (+76.5%) to their portfolio in Q4 2025, for an estimated $5,882,332
- HITE HEDGE ASSET MANAGEMENT LLC removed 827,701 shares (-56.6%) from their portfolio in Q4 2025, for an estimated $4,386,815
- NUVEEN, LLC added 779,709 shares (+785.0%) to their portfolio in Q4 2025, for an estimated $4,132,457
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
NB Analyst Ratings
Wall Street analysts have issued reports on $NB in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- William Blair issued a "Outperform" rating on 10/20/2025
- HC Wainwright & Co. issued a "Buy" rating on 09/22/2025
To track analyst ratings and price targets for NB, check out Quiver Quantitative's $NB forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$220,000 of RIVIAN AUTOMOTIVE LLC lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues affecting automotive and automotive supply chain in the US, including consumer tax incentives, commercial tax incentives, and emissions standards. Issues affecting autonomous vehicles, including SELF DRIVE Act Issues affecting manufacturing investment in the US, including the 45X battery investment credit and the Advanced Technology Vehicle Manufacturing program. Tariffs affecting the automotive indutry"
You can find more data on corporate lobbying on Quiver Quantitative.
RIVN Insider Trading Activity
RIVN insiders have traded $RIVN stock on the open market 14 times in the past 6 months. Of those trades, 0 have been purchases and 14 have been sales.
Here’s a breakdown of recent trading of $RIVN stock by insiders over the last 6 months:
- ROBERT J SCARINGE (Chief Executive Officer) has made 0 purchases and 10 sales selling 209,400 shares for an estimated $3,508,073.
- CLAIRE MCDONOUGH (Chief Financial Officer) has made 0 purchases and 3 sales selling 56,382 shares for an estimated $963,870.
- PETER KRAWIEC sold 3,655 shares for an estimated $71,076
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
RIVN Hedge Fund Activity
We have seen 342 institutional investors add shares of RIVN stock to their portfolio, and 376 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 40,081,320 shares (-75.4%) from their portfolio in Q4 2025, for an estimated $790,002,817
- JPMORGAN CHASE & CO added 16,373,939 shares (+287.6%) to their portfolio in Q4 2025, for an estimated $322,730,337
- D. E. SHAW & CO., INC. added 9,282,134 shares (+212.3%) to their portfolio in Q4 2025, for an estimated $182,950,861
- TWO SIGMA ADVISERS, LP added 6,379,420 shares (+44.7%) to their portfolio in Q4 2025, for an estimated $125,738,368
- JANE STREET GROUP, LLC removed 5,783,322 shares (-80.8%) from their portfolio in Q4 2025, for an estimated $113,989,276
- UBS GROUP AG removed 5,577,143 shares (-28.6%) from their portfolio in Q4 2025, for an estimated $109,925,488
- WORLDQUANT MILLENNIUM ADVISORS LLC removed 4,578,845 shares (-86.7%) from their portfolio in Q4 2025, for an estimated $90,249,034
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
RIVN Analyst Ratings
Wall Street analysts have issued reports on $RIVN in the last several months. We have seen 4 firms issue buy ratings on the stock, and 2 firms issue sell ratings.
Here are some recent analyst ratings:
- Deutsche Bank issued a "Buy" rating on 02/13/2026
- Wolfe Research issued a "Underperform" rating on 01/12/2026
- Baird issued a "Outperform" rating on 12/18/2025
- Stifel issued a "Buy" rating on 11/17/2025
- Tigress Financial issued a "Buy" rating on 11/14/2025
- Mizuho issued a "Underperform" rating on 10/20/2025
To track analyst ratings and price targets for RIVN, check out Quiver Quantitative's $RIVN forecast page.
RIVN Price Targets
Multiple analysts have issued price targets for $RIVN recently. We have seen 17 analysts offer price targets for $RIVN in the last 6 months, with a median target of $18.0.
Here are some recent targets:
- Stephen Gengaro from Stifel set a target price of $20.0 on 02/17/2026
- Michael Shlisky from DA Davidson set a target price of $14.0 on 02/17/2026
- Joseph Spak from UBS set a target price of $16.0 on 02/13/2026
- Colin Langan from Wells Fargo set a target price of $15.0 on 02/13/2026
- Alexander Potter from Piper Sandler set a target price of $18.0 on 02/13/2026
- Dan Ives from Wedbush set a target price of $25.0 on 02/13/2026
- Mickey Legg from Benchmark set a target price of $25.0 on 02/13/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$1,360,000 of CORTEVA AGRISCIENCE LLC (FKA E I DU PONT DE NEMOURS AND COMPANY) lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Implementation and oversight of the Agriculture Marketing Act of 1946 to require the Secretary of Proposed update to plant incorporated protectant rule and proposed update to guidance clarifying the regulatory approach for food from plantsdeveloped with the newest tools of genome editing. 7CFR Part 340 Pesticide Matters Seed Matters Climate change matters 2024 Farm Bill Endangered Species Act and Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) Biostimulant regulatory matters Pesticide matters Farm Bill 2024 Endangered Species Act and Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) Pesticide matters Climate change matters Trade Intellectual property rights and protection Agriculture trade Trade and international relations Tariff matters Seed trade matters Issues related to Mexico's regulation of agricultural biotechnology and pesticides Corporate taxation matters Taxation matters impacting US farmers 2025 NDAA Intellectual property rights and protection Technology access"
You can find more data on corporate lobbying on Quiver Quantitative.
CTVA Insider Trading Activity
CTVA insiders have traded $CTVA stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $CTVA stock by insiders over the last 6 months:
- BRIAN TITUS (See Remarks) has made 0 purchases and 2 sales selling 8,311 shares for an estimated $636,199.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CTVA Hedge Fund Activity
We have seen 576 institutional investors add shares of CTVA stock to their portfolio, and 725 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 11,456,910 shares (-75.4%) from their portfolio in Q4 2025, for an estimated $767,956,677
- CAPITAL INTERNATIONAL INVESTORS removed 10,801,587 shares (-92.8%) from their portfolio in Q4 2025, for an estimated $724,030,376
- HARRIS ASSOCIATES L P added 10,675,052 shares (+168.1%) to their portfolio in Q4 2025, for an estimated $715,548,735
- FMR LLC added 5,962,615 shares (+25.8%) to their portfolio in Q4 2025, for an estimated $399,674,083
- JANUS HENDERSON GROUP PLC removed 3,132,619 shares (-29.2%) from their portfolio in Q4 2025, for an estimated $209,979,451
- NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO added 3,100,709 shares (+6527.4%) to their portfolio in Q4 2025, for an estimated $207,840,524
- BLACKROCK, INC. added 2,901,736 shares (+5.1%) to their portfolio in Q4 2025, for an estimated $194,503,364
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CTVA Analyst Ratings
Wall Street analysts have issued reports on $CTVA in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 10/30/2025
- Wells Fargo issued a "Overweight" rating on 10/16/2025
- Argus Research issued a "Buy" rating on 10/13/2025
To track analyst ratings and price targets for CTVA, check out Quiver Quantitative's $CTVA forecast page.
CTVA Price Targets
Multiple analysts have issued price targets for $CTVA recently. We have seen 10 analysts offer price targets for $CTVA in the last 6 months, with a median target of $80.0.
Here are some recent targets:
- John Roberts from Mizuho set a target price of $82.0 on 02/17/2026
- Jeffrey Zekauskas from JP Morgan set a target price of $77.0 on 02/05/2026
- Arun Viswanathan from RBC Capital set a target price of $89.0 on 02/05/2026
- Michael Sison from Wells Fargo set a target price of $85.0 on 02/05/2026
- Patrick Cunningham from Citigroup set a target price of $80.0 on 02/05/2026
- Kristen Owen from Oppenheimer set a target price of $78.0 on 01/27/2026
- Joshua Spector from UBS set a target price of $81.0 on 10/30/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$40,000 of ZOOMINFO TECHNOLOGIES LLC lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to consumer privacy legislation, specifically affecting B2B businesses. Issues related to consumer privacy legislation, specifically affecting B2B businesses."
You can find more data on corporate lobbying on Quiver Quantitative.
GTM Insider Trading Activity
GTM insiders have traded $GTM stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $GTM stock by insiders over the last 6 months:
- JAMES M ROTH (Chief Revenue Officer) has made 0 purchases and 4 sales selling 62,986 shares for an estimated $485,611.
- ASHLEY MCGRANE (General Counsel and Corp Sec) has made 0 purchases and 7 sales selling 9,799 shares for an estimated $110,508.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
GTM Hedge Fund Activity
We have seen 164 institutional investors add shares of GTM stock to their portfolio, and 231 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MACQUARIE GROUP LTD removed 16,728,210 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $170,125,895
- CONTOUR ASSET MANAGEMENT LLC removed 3,840,173 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $39,054,559
- PACER ADVISORS, INC. added 3,358,108 shares (+8942.1%) to their portfolio in Q4 2025, for an estimated $34,151,958
- POINT72 ASSET MANAGEMENT, L.P. removed 3,122,271 shares (-75.3%) from their portfolio in Q4 2025, for an estimated $31,753,496
- HOOD RIVER CAPITAL MANAGEMENT LLC removed 2,858,740 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $31,188,853
- LSV ASSET MANAGEMENT added 2,674,753 shares (+35.6%) to their portfolio in Q4 2025, for an estimated $27,202,238
- FMR LLC added 2,604,302 shares (+12.5%) to their portfolio in Q4 2025, for an estimated $26,485,751
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
GTM Analyst Ratings
Wall Street analysts have issued reports on $GTM in the last several months. We have seen 2 firms issue buy ratings on the stock, and 3 firms issue sell ratings.
Here are some recent analyst ratings:
- Jefferies issued a "Buy" rating on 02/03/2026
- BTIG issued a "Buy" rating on 12/17/2025
- Goldman Sachs issued a "Sell" rating on 11/04/2025
- RBC Capital issued a "Underperform" rating on 11/04/2025
- Wells Fargo issued a "Underweight" rating on 10/01/2025
To track analyst ratings and price targets for GTM, check out Quiver Quantitative's $GTM forecast page.
GTM Price Targets
Multiple analysts have issued price targets for $GTM recently. We have seen 13 analysts offer price targets for $GTM in the last 6 months, with a median target of $9.0.
Here are some recent targets:
- Clark Wright from DA Davidson set a target price of $7.0 on 02/11/2026
- Tyler Radke from Citigroup set a target price of $6.5 on 02/11/2026
- Raimo Lenschow from Barclays set a target price of $9.0 on 02/11/2026
- Siti Panigrahi from Mizuho set a target price of $10.0 on 02/10/2026
- Elizabeth Porter from Morgan Stanley set a target price of $9.0 on 02/10/2026
- Taylor McGinnis from UBS set a target price of $8.5 on 02/10/2026
- Rishi Jaluria from RBC Capital set a target price of $7.0 on 02/10/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$3,170,000 of FEDEX CORPORATION lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"H.R.574/S.187 - ALIGN Act Legislative monitoring for tax credits involving EVs, SAFs, and zero emission charging infrastructure. Corporate and international tax issues related to the Tax Cuts and Jobs Act. H.R.1062 - Growing and Preserving Innovation in America Act of 2025. General monitoring of administration policy and Executive Orders. H.R.1 - The One Big Beautiful Bill. H.R. 1177/S. 492-Improve and Enhance the Work Opportunity Tax Credit Act. Legislative monitoring of U.S. Postal Service-related issues. General monitoring of administration policy and Executive Orders. S.1604 - No RTO Act. H.R.3004 - USPS SERVES US Act. S. 986 - STOP Act 2.0. H.R. 3011 - USPS Shipping Equity Act. H.Res.70/S.Res.147 - Expressing the sense of the House of Representatives that Congress should take all appropriate measures to ensure that the United States Postal Service remains an independent establishment of the Federal Government and is not subject to privatization. Legislative monitoring of Open Skies Agreements. Legislative monitoring of general trade issues including customs modernization, GSP, MTB, IPEF, CBAM, and de minimis. Legislative monitoring around China PNTR. Foreign Pollution Fee Act of 2025. S.1259 - Manifest Modernization Act of 2025. H.R.1840 - Closing the De Minimis Loophole Act. H.R.805 - End Chinas De Minimis Abuse Act. H.R.322 - Import Security and Fairness Act. H.R.1504 - China Trade Relations Act of 2025. H.R.694 - Restoring Trade Fairness Act. S.206 - Restoring Trade Fairness Act. H.R.407 - Prevent Tariff Abuse Act. S.956 - Customs Facilitation Act of 2025. H.R.1 - The One Big Beautiful Bill. General monitoring of administration policy and Executive Orders. H.Con.Res.14 - A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 . FY 2026 Transportation, Housing, and Urban Development, and Related Agencies Appropriations bills. FY 2026 Homeland Security (DHS) Appropriations General monitoring of administration policy and Executive Orders. Legislative monitoring on aviation security and aviation safety issues including all-cargo flight time and duty rules; ATC modernization; and Open Skies agreements. General monitoring of administration policy and Executive Orders. S.1985 - Safe Operations of Shared Airspace Act of 2025. S.1706 - A bill to require aircraft operating in Class B airspace in the national airspace system to install and operate ADS-B In and ADS-B Out equipment, and for other purposes. S.2503 - Rotorcraft Operations Transparency and Oversight Reform Act. Transporation Security Reauthorization Act. H.R.2424 - Modern, Clean, and Safe Trucks Act of 2025. H.R.2391 - Strengthening the Supply Chain Through Truck Drivers Incentives Act of 2025. H.R.1659 - Truck Parking Safety Improvement Act. H.R.2514 - Trucker Bathroom Access Act. H.R. 2954/S. 1537 - Veterans Transition to Trucking Act of 2025. S.711 - Transportation Freedom Act. General monitoring of the DOT English Language Proficiency Rule. Legislative monitoring of AV bills, including vehicle data ownership and zero occupant vehicles. General monitoring of administration policy and Executive Orders. Surface Transportation Reauthorization Draft. H.R.3373 - GHOST Act. S.345/H.R.850 - Silencers Help Us Save Hearing (SHUSH) Act. General monitoring of legislation related to shipping restricted commodities. H.R.20/S.852 - Richard L. Trumka Protecting the Right to Organize Act of 2025. H.R.1962/S.893 - Guaranteeing Overtime For Truckers Act. H.R. 4366 - Save Local Business Act. H.R. 5267 - American Franchise Act. S.844 - Faster Labor Contracts Act. S. 2163 - Warehouse Worker Protection Act. DOL Independent Contractor Rule. NLRB Joint Employer Rule. Package Delivery Parity Act Discussion Draft. Legislative monitoring of activity related to the Railway Labor Act (RLA). General monitoring of the OSHA Walkaround Rule. General monitoring of the OSHA Heat Illness Rule. General monitoring of administration policy and Executive Orders. Legislative monitoring of H1b visas and critical worker immigration. General monitoring of administration policy and Executive Orders. Legislative monitoring of consumer privacy issues, vehicle data issues, and AI. H.R.1566 - REPAIR Act. H.R.1664/S.1492 - Deploying American Blockchains Act of 2025. General monitoring of administration policy and Executive Orders. Legislative monitoring of federal contracting issues. General monitoring of administration policy and Executive Orders. S.382/H.R.925 - Dismantle DEI Act S. 2296, the National Defense Authorization Act for FY 2026"
You can find more data on corporate lobbying on Quiver Quantitative.
FDX Congressional Stock Trading
Members of Congress have traded $FDX stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $FDX stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 01/09.
- REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
FDX Hedge Fund Activity
We have seen 822 institutional investors add shares of FDX stock to their portfolio, and 871 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 4,071,468 shares (-75.3%) from their portfolio in Q4 2025, for an estimated $1,176,084,246
- FMR LLC added 2,053,626 shares (+69.5%) to their portfolio in Q4 2025, for an estimated $593,210,406
- PRIMECAP MANAGEMENT CO/CA/ removed 929,579 shares (-9.8%) from their portfolio in Q4 2025, for an estimated $268,518,189
- BALYASNY ASSET MANAGEMENT L.P. added 745,703 shares (+27008.4%) to their portfolio in Q4 2025, for an estimated $215,403,768
- WADDELL & ASSOCIATES, LLC added 738,122 shares (+164.0%) to their portfolio in Q4 2025, for an estimated $213,213,920
- CAPITAL INTERNATIONAL INVESTORS removed 685,766 shares (-15.9%) from their portfolio in Q4 2025, for an estimated $198,090,366
- DODGE & COX removed 642,992 shares (-4.0%) from their portfolio in Q4 2025, for an estimated $185,734,669
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
FDX Analyst Ratings
Wall Street analysts have issued reports on $FDX in the last several months. We have seen 5 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Stifel issued a "Buy" rating on 12/19/2025
- Morgan Stanley issued a "Underweight" rating on 12/19/2025
- Truist Securities issued a "Buy" rating on 12/19/2025
- Stephens & Co. issued a "Overweight" rating on 12/19/2025
- Citigroup issued a "Buy" rating on 12/19/2025
- Jefferies issued a "Buy" rating on 12/19/2025
To track analyst ratings and price targets for FDX, check out Quiver Quantitative's $FDX forecast page.
FDX Price Targets
Multiple analysts have issued price targets for $FDX recently. We have seen 18 analysts offer price targets for $FDX in the last 6 months, with a median target of $337.5.
Here are some recent targets:
- Jonathan Chappell from Evercore ISI Group set a target price of $380.0 on 02/24/2026
- Fadi Chamoun from BMO Capital set a target price of $400.0 on 02/13/2026
- Jason H. Seidl from TD Cowen set a target price of $383.0 on 02/13/2026
- Christian Wetherbee from Wells Fargo set a target price of $430.0 on 02/13/2026
- Reed Seay from Stephens & Co. set a target price of $405.0 on 02/13/2026
- Brandon Oglenski from Barclays set a target price of $450.0 on 02/10/2026
- Ariel Rosa from Citigroup set a target price of $401.0 on 02/05/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$380,000 of CHUBB INA HOLDINGS INC. lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Various Issues related to the Federal Insurance Office (FIO) and Federal Advisory Committee on Insurance (FACI). Issues related to international capital standards and covered agreements. Issues related to/impacting cyber insurance coverage, ransomware and incident reporting. Issues related to Privacy legislation. Issues related to various Surety & Fidelity Bond requirements. Issues related to risk mitigation and resiliency. Issues related to insurance coverage for various natural catastophes. Issues related to the National Flood Insurance Program (NFIP). Issues related to cannabis safe harbor for insurers. S. 570 / H.R. 1285 - Water Infrastructure Subcontractor and Taxpayer Protection Act. S. 245 - Insure CyberSecurity Act. Issues related to Artificial Intelligence. H.R.643 - Federal Insurance Office Elimination Act S.1544/H.R.3437 - Insurance Data Protection Act Reauthorization of the Cybersecurity Information Sharing Act of 2015 Issues related to international tax proposals. Issues related to third party litigation funding and lawsuit lending. Issues related to U.S. engagement in OECD tax initiatives. Issues related to TCJA extension & various corporate and insurance related tax provisions. S.1821/H.R.3512 - Tackling Predatory Litigation Funding Act. H.R.1 - One Big Beautiful Bill Act Issues related to Mexico's VAT. Issues related to the implementation and review of the U.S.-Mexico-Canada Agreement. Discussions on China-related legislation. Issues related to digital trade, data flows and Artificial Intelligence. Issues related to Sanctions. Issues related to Investment. Issues related to U.S.-Swiss Tax treaty. Issues related to Malaysia divestment requirement. Issues related to U.S. tariffs and trade negotiations. Various issues related to transparency in asbestos bankruptcy trusts. Various tort reform and liability related issues. Issues surrounding arbitration clauses in contracts. Issues related to third party litigation funding and lawsuit lending. S. 706 / H.R. 1530 - Ensuring Justice for Victims of Terrorism Act. H.R. 2675 - Protecting our Courts from Foreign Manipulation Act of 2025."
You can find more data on corporate lobbying on Quiver Quantitative.
CB Congressional Stock Trading
Members of Congress have traded $CB stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $CB stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 01/09.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
CB Insider Trading Activity
CB insiders have traded $CB stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $CB stock by insiders over the last 6 months:
- JOHN J LUPICA (Vice Chrm, Chubb Group*) has made 0 purchases and 2 sales selling 40,073 shares for an estimated $11,513,506.
- EVAN G GREENBERG (Chairman & CEO) has made 0 purchases and 2 sales selling 29,985 shares for an estimated $9,993,140.
- TIMOTHY ALAN BOROUGHS (Executive Vice President*) has made 0 purchases and 2 sales selling 11,430 shares for an estimated $3,384,390.
- JOSEPH F WAYLAND (Executive Vice President and*) sold 5,830 shares for an estimated $1,731,976
- GEORGE F. OHSIEK (Chief Accounting Officer) has made 0 purchases and 2 sales selling 5,140 shares for an estimated $1,672,698.
- JUAN LUIS ORTEGA (Executive Vice President*) sold 4,357 shares for an estimated $1,285,489
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CB Hedge Fund Activity
We have seen 950 institutional investors add shares of CB stock to their portfolio, and 923 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ added 3,049,987 shares (+25.6%) to their portfolio in Q4 2025, for an estimated $951,961,942
- BERKSHIRE HATHAWAY INC added 2,916,288 shares (+9.3%) to their portfolio in Q4 2025, for an estimated $910,231,810
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 2,548,307 shares (+inf%) to their portfolio in Q4 2025, for an estimated $795,377,580
- GQG PARTNERS LLC added 1,647,729 shares (+15.2%) to their portfolio in Q4 2025, for an estimated $514,289,175
- FMR LLC removed 1,468,730 shares (-11.9%) from their portfolio in Q4 2025, for an estimated $458,420,007
- AQR CAPITAL MANAGEMENT LLC added 1,443,335 shares (+51.6%) to their portfolio in Q4 2025, for an estimated $450,493,720
- VIKING GLOBAL INVESTORS LP added 1,013,839 shares (+inf%) to their portfolio in Q4 2025, for an estimated $316,439,428
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CB Analyst Ratings
Wall Street analysts have issued reports on $CB in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Goldman Sachs issued a "Buy" rating on 01/08/2026
- Keefe, Bruyette & Woods issued a "Outperform" rating on 01/06/2026
- JMP Securities issued a "Market Outperform" rating on 10/22/2025
- Evercore ISI Group issued a "Outperform" rating on 10/01/2025
To track analyst ratings and price targets for CB, check out Quiver Quantitative's $CB forecast page.
CB Price Targets
Multiple analysts have issued price targets for $CB recently. We have seen 18 analysts offer price targets for $CB in the last 6 months, with a median target of $337.5.
Here are some recent targets:
- Michael Zaremski from BMO Capital set a target price of $326.0 on 02/10/2026
- Matthew Heimermann from Citigroup set a target price of $385.0 on 02/09/2026
- Meyer Shields from Keefe, Bruyette & Woods set a target price of $373.0 on 02/09/2026
- C. Gregory Peters from Raymond James set a target price of $380.0 on 02/09/2026
- Yaron Kinar from Mizuho set a target price of $336.0 on 02/06/2026
- Elyse Greenspan from Wells Fargo set a target price of $322.0 on 02/05/2026
- David Motemaden from Evercore ISI Group set a target price of $347.0 on 02/04/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$20,000 of INVIVYD INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"None"
You can find more data on corporate lobbying on Quiver Quantitative.
IVVD Insider Trading Activity
IVVD insiders have traded $IVVD stock on the open market 11 times in the past 6 months. Of those trades, 1 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $IVVD stock by insiders over the last 6 months:
- KEVIN F MCLAUGHLIN purchased 50,000 shares for an estimated $125,000
- JILL ANDERSEN (Chief Legal Officer, Secretary) has made 0 purchases and 2 sales selling 67,710 shares for an estimated $105,580.
- WILLIAM E. DUKE (Chief Financial Officer) has made 0 purchases and 2 sales selling 40,627 shares for an estimated $63,350.
- JULIE GREEN (Chief Human Resources Officer) has made 0 purchases and 2 sales selling 40,627 shares for an estimated $63,350.
- TIMOTHY EDWARD LEE (Chief Commercial Officer) has made 0 purchases and 2 sales selling 40,627 shares for an estimated $63,350.
- ROBERT D. III ALLEN (Chief Scientific Officer) has made 0 purchases and 2 sales selling 37,581 shares for an estimated $58,600.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
IVVD Hedge Fund Activity
We have seen 72 institutional investors add shares of IVVD stock to their portfolio, and 40 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PERCEPTIVE ADVISORS LLC added 21,785,166 shares (+inf%) to their portfolio in Q4 2025, for an estimated $53,809,360
- BVF INC/IL added 19,525,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $48,226,750
- DEEP TRACK CAPITAL, LP removed 8,585,980 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $9,444,578
- SATURN V CAPITAL MANAGEMENT LP added 7,735,386 shares (+inf%) to their portfolio in Q4 2025, for an estimated $19,106,403
- SOLEUS CAPITAL MANAGEMENT, L.P. added 7,708,727 shares (+inf%) to their portfolio in Q4 2025, for an estimated $19,040,555
- JANUS HENDERSON GROUP PLC added 7,160,065 shares (+28.2%) to their portfolio in Q4 2025, for an estimated $17,685,360
- EVENTIDE ASSET MANAGEMENT, LLC added 5,809,256 shares (+inf%) to their portfolio in Q4 2025, for an estimated $14,348,862
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
IVVD Analyst Ratings
Wall Street analysts have issued reports on $IVVD in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 12/23/2025
- HC Wainwright & Co. issued a "Buy" rating on 11/03/2025
- Cantor Fitzgerald issued a "Overweight" rating on 10/06/2025
To track analyst ratings and price targets for IVVD, check out Quiver Quantitative's $IVVD forecast page.
IVVD Price Targets
Multiple analysts have issued price targets for $IVVD recently. We have seen 4 analysts offer price targets for $IVVD in the last 6 months, with a median target of $10.0.
Here are some recent targets:
- Thomas Shrader from BTIG set a target price of $10.0 on 12/23/2025
- Patrick R. Trucchio from HC Wainwright & Co. set a target price of $10.0 on 11/03/2025
- Josh Schimmer from Cantor Fitzgerald set a target price of $10.0 on 10/06/2025
- Jason Kolbert from D. Boral Capital set a target price of $2.0 on 10/06/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.